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 This dissertation research explored the capabilities of neuronal networks grown 
on substrate integrated microelectrode arrays in vitro with emphasis on utilizing such 
preparations in three specific application domains: pharmacology and drug development, 
biosensors and neurotoxicology, and the study of burst and synaptic mechanisms. 
Chapter 1 details the testing of seven novel AChE inhibitors, demonstrating that neuronal 
networks rapidly detect small molecular differences in closely related compounds, and 
reveal information about their probable physiological effects that are not attainable 
through biochemical characterization alone. Chapter 2 shows how neuronal networks 
may be used to classify and characterize an unknown compound. The compound, 
trimethylol propane phosphate (TMPP) elicited changes in network activity that 
resembled those induced by bicuculline, a known epileptogenic. Further work determined 
that TMPP produces its effects on network activity through a competitive inhibition of 
the GABAA receptor. This demonstrates that neuronal networks can provide rapid, 
reliable warning of the presence of toxic substances, and from the manner in which the 
spontaneous activity changes provide information on the class of compound present and 
its potential physiological effects. Additional simple pharmacological tests can provide 
valuable information on primary mechanisms involved in the altered neuronal network 
responses.  
Chapter 3 explores the effects produced by a radical simplification of synaptic 
driving forces. With all synaptic interactions pharmacologically limited to those mediated 
through the NMDA synapse, spinal cord networks exhibited an extremely regular burst 
oscillation characterized by a period of 2.9 ± 0.3 s, with mean coefficients of variation of 
3.7, 4.7, and 4.9 % for burst rate, burst duration, and inter-burst interval, respectively (16 
separate cultures). The reliability of expression of this oscillation suggests that it may 
represent a fundamental mechanism of importance during periods of NMDA receptor 
dominated activity, such as embryonic and early postnatal development. NMDA synapse 
mediated activity produces a precise oscillatory state that allows the study of excitatory-

























































“Mine is the first step and therefore a small one, though worked out with much thought 
and hard labor. You, my readers or hearers of my lectures, if you think I have done as 
much as can fairly be expected of an initial start. … will acknowledge what I have 
achieved and will pardon what I have left for others to accomplish" 
 
Aristotle of Stagirus 
 
 
"What I see in Nature is a magnificent structure that we can comprehend only very 
imperfectly, and that must fill a thinking person with a feeling of "humility." This is a 





“Nothing tends so much to the advancement of knowledge as the application of a new 
instrument. The native intellectual powers of men in different times are not so much the 
causes of the different success of their labours, as the peculiar nature of the means and 
artificial resources in their possession." 
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Growing interest in acute and chronic effects of environmental toxins, increasing 
awareness of the threats posed by chemical or biological terrorism, and the accelerating 
pace of drug discovery require the development of new tools for rapid detection and 
prediction of the effects of a wide range of molecular species. For example, current 
technologies relying on antibody, electrochemical, mass spectrometry, or nucleic acid 
recognition offer highly sensitive and specific detection of many compounds. The 
disadvantages of many of these systems lie in their very specificity. They are exquisitely 
sensitive for compounds they are tuned to detect, for example, antibody detection of 5-10 
ng/ml of botulinum toxoid can be rapidly accomplished (Emanuel et al., 2000). However, 
compounds not matched to the recognition pocket in these assays are invisible. 
Additionally, detection of a particular compound by these methods provides no 
information on the potential physiological consequences of exposure to the detected 
agent. A toxin epitope may be recognized by an antibody-based detector, but be 
physiologically inactive because of prior exposure to denaturing conditions. In the 
development of new drugs, a novel compound may be completely characterized 
biochemically, but may possess secondary effects in a physiological assay that renders it 
unsuitable for clinical applications. Thus, a system is needed that can provide rapid, 
broad-spectrum, yet sensitive, detection of environmental and novel compounds with 
information on the physiological consequences of exposure. 
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Cultured neuronal networks possess these capabilities. When coupled to circuitry 
to enabling transduction of extracellular electrical activity, these networks provide a 
tissue-based sensor that responds to a wide variety of compounds (Gross, 1994; Gross et 
al., 1992, 1995, 1997a,b). The advantages of neuronal networks, compared systems such 
as the antibody based ones discussed in the previous paragraph, lie both in the ability to 
detect unexpected compounds and generate meaningful physiological information on the 
effects of those compounds. 
 
One proposed use of cultured neuronal networks is as a tissue-based biosensor for 
both military and civilian applications (Gross et al., 1995, Gross et al., 1992). A tissue-
based biosensor may be defined as a device that monitors changes in the physiological 
activity of living cells caused by exposure to environmental perturbations. The state-of-
the art in portable tissue-based biosensors that can be transported outside of a laboratory 
environment remains, as it has for at least one hundred years, the canary in a cage. 
Canaries were used in the 18th and 19th centuries to detect methane gas in coal mines. 
They were the detector of choice in 1995 for Japanese police, who employed the birds in 
their raid of the Aum Shin Rikyo sect, members of which carried out a Sarin nerve gas 
attack on the Tokyo subway system. Other live animals, such as chickens, fish, and clams 
are used today to detect agents such as encephalitis viruses and water contaminates.  
 
Tissue-based biosensors utilizing cultured cells instead of whole animals offer 
several advantages, including the ability to automate the monitoring process and a 
reduction in the numbers of animals required for sensing elements. Most important, 
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tissue-based systems utilizing mammalian cell sources can yield physiologically relevant 
data on the nature of a detected threat, which may be extrapolated to the anticipated effect 
should a human be exposed. Several research programs designed to develop tissue-based 
biosensors for military and civilian use, have been created. These include the current 
Defense Advanced Research Projects Agency (DARPA) Tissue-Based Biosensor 
program. Numerous cell types, including bacteria, algae, lymphocytes, hepatocytes, 
chromatophores, alveolar macrophages, cardiomyocytes, and neurons have been tested as 
substrates for biosensors under the aegis of the DARPA program.  
 
Neurons are particularly attractive biosensor elements, as they combine an array 
of cell-surface receptors, which have been evolutionarily selected to respond to a broad 
spectrum of diverse substances, with an electrically excitable membrane. Thus, real-time 
information may be obtained on the consequences of receptor activation or interference 
with the mechanisms maintaining the neuronal membrane potential. Cultured neuronal 
networks grown on substrate-integrated thin-film micro-electrode arrays (MEAs) (Gross, 
1979), take advantage of these characteristics. Additionally, by utilizing networks of 
neurons instead of single cells, the actions of unknown compounds may be interpreted in 
the context of physiologically behaving systems, and may provide redundancy in the 
detection mechanism.  
 
The dissociation of embryonic neural tissue produces isolated neuron and glial 
cells.  When both are seeded on electrode arrays prepared with suitable adhesion 
molecules, such as poly-lysine and laminin, a shallow three-dimensional tissue develops 
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with neuronal cell bodies growing generally on top of a flat glia carpet and with neuronal 
processes situated both above and below that carpet.  The initial stages of organization 
seem to be determined by a competition between cell-cell and cell-substrate adhesion. 
There appears to be a correlation between morphological stabilization of the network and 
the initiation of bursting, which commonly occurs in the second to third week of in vitro 
development.  
 
Neuron-electrical hybrid systems offer speed and sensitivity of detection, with 
robust changes in network behavior elicited by compounds such as tetrodotoxin and 
strychnine in the low nanomolar range (Gross et al., 1997; Harsch et al., 1997). Detection 
of low picomolar concentrations of compounds such as botulinum toxin is possible 
(unpublished observations). The use of such systems for automated monitoring of 
environmental threats and drug development is made more practical by the rapid increase 
in processing speeds and availability of personal computers. Analysis algorithms which 
formerly required off-line processing by dedicated computer systems now can be run in 
real time by laptop machines.  
 
Several challenges remain for the realization of neuronal networks as common 
tools in biosensor and drug development domains. Among them are: a) the demonstration 
of reliability and reproducibility of responses; b) the ability to produce and distribute 
large numbers of cultures that possess those reliable and reproducible responses; c) the 
development of life support systems for maintenance of the cultures in remote locations; 
and d) the implementation of automatic data analysis algorithms that will provide 
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unskilled operators with a meaningful interpretation of changes in network activity. 
Progress in each of these areas is being made. However, the biosensor application may 
ultimately be hindered less by the limitations of the neuronal networks themselves, than 
by the lack of suitable technology with which to extract environmental contaminants 
from the air and water; and then concentrate, sterilize, and deliver those contaminants to 
the neuronal network for analysis. 
 
Thus, it is anticipated that the first of large-scale use of neuronal networks will 
come in the area of drug development. The pharmaceutical industry has a profound need 
for a device to provide information on the neuroactivity of large numbers of potential 
drugs. The number of compounds waiting to be screened may exceed 2-3 million (H. 
Hammerle, University of Tubingen, personal communication). Additionally, current 
methods used in rational drug development require the synthesis of large numbers of 
closely related molecules in an effort to discover the molecular configuration that imparts 
a desired effect and to eliminate those configurations that yield deleterious effects. This 
results in huge families of novel molecules, each of which must be screened in some way. 
The only method currently available for testing for neuroactivity and neurotoxicity uses 
live animals such as mice, rats, and chickens. This is an enormously expensive 
methodology, in both monetary costs and animal lives. A screening procedure based upon 
cultured neuronal networks should result in large cost savings, as well as prove a more 
humane alternative in that it requires minimal numbers of animals to be sacrificed to 
obtain the necessary tissue. 
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Advances in neurobiology have enabled rapid progress on the cellular and whole 
animal levels. However, the fundamental processing unit within the brain may be small 
groups of neurons that transiently and dynamically associate, with the degree and 
duration of the association determined by sensory input (Edelman, G, 1987). This level of 
neurobiological processing is relatively well characterized for some phenomena, such as 
rhythmic pattern generation within the spinal cord and the respiratory center (Grillner et 
al., 2000, Smith et al., 1991). This processing was not characterized in other areas such as 
the motor cortex, however, until the availability of multielectrode technology allowed 
researchers to study the mechanisms of population coding (Chapin et al., 1999; 
Georgopoulos et al., 1986; Schwartz A, 1994).  
 
Cultured neuronal networks offer a preparation in which group processing may be 
studied conveniently. Such networks are isolated from afferent input that often 
complicates interpretation of changes in behaving animals. Pharmacological 
manipulations may be performed rapidly and repeatedly, allowing isolation of particular 
neurotransmitter systems. Electrical stimulation is possible through the same electrodes 
used to record. Long-term monitoring of networks has been limited to date only by 
contamination and has reached 16 days in an open chamber configuration. Experiments 
of several months' duration are foreseeable, with only minor improvements in network 
environmental control necessary.  
 
As previously mentioned, the computing capabilities necessary for handling the 
large data streams from multichannel recording have become widely available and 
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affordable only recently. With these new systems will come new data analysis and 
visualization techniques. Such innovations promise rapid progress in the understanding of 
many network ensemble properties, such as pattern generation and storage, spontaneous 
shifts in dynamic neuronal associations, and fault-tolerance limits of network processing. 
The study of network development, the contributions of different neurotransmitter 
systems to network behavior, and the neuropathophysiology of various diseases, such as 
Alzheimer's, and infectious agents like HIV, may be expedited by cultured neuronal 
networks. These networks bridge cellular and whole animal physiology, and will yield 
valuable insights into the chemical and biological processes required to facilitate the 
association of single neuronal elements into highly interconnected neuronal networks as 
well as the emergent computational abilities of such networks. 
 
The purpose of this work is to demonstrate the use of neuronal networks cultured 
on multi-electrode arrays in drug development, biosensors and neurtoxicology, and the 
study of burst mechanisms. In Chapter 1, the acute effects of a battery of novel 
acetylcholinestase inhibitors and common cholinergic compounds, including 
physostigmine and carbachol, will be described. This study highlights the ability of 
neuronal networks to detect minor molecular differences in a series of compounds that 
possess nearly identical AChE inhibition constants. Additionally, it offers a clear 
example of the advantage of supplementing biochemical characterization with 
physiological information. Two of the seven novel compounds tested produced 
irreversible inhibition of neuronal activity, an effect that could not be predicted from the 
biochemical data. This response implies a potentially lethal side-effect if the compounds 
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were to be administered to living animals. With physiological information provided by 
the neuronal networks, compounds with undesirable consequences can be eliminated 
prior to expensive, time-consuming animal testing.  
 
Chapter 2 offers an example of neuronal network detection and classification of 
an unidentified compound. This compound, trimethylol propane phosphate (TMPP), was 
supplied by the Naval Research Laboratory, (Washington D.C.) as a blind test. After four 
experiments over a period of three days, it was determined that TMPP had effects on the 
organization of network activity at concentrations as low as 2µM, and that these effects 
resembled those of known epileptogenic substances, such as bicuculline. These 
conclusions confirmed experiments performed with acute and chronically dosed rats over 
a two-year period at the Naval Health Research Center, Wright-Patterson Air Force Base. 
Further characterization of TMPP by the neuronal networks demonstrated that it 
functions as an antagonist at the GABAA receptor, a property that correlates with its 
disinhibitory effects on network activity. The methodology outlined in the detection and 
classification of TMPP provides a basis for future applications of neuronal networks as 
biosensors and demonstrates the possible utility of compiling a reference library of 
network response to pharmacological compounds. This library of substance 
“fingerprints” will facilitate classification of unknown compounds by matching the 
responses they elicit to those of a known compound and will expand the capabilities of 
neuronal network sensors beyond that of simple threat detectors. 
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Chapter 3 details a series of 16 experiments using spinal cord cultures in which all 
neuronal synaptic interactions were limited to those mediated by the N-methyl-D-
aspartate (NMDA) type glutamate receptor. This pharmacological state provides a model 
of the excitatory-coupled networks found during brief periods of mammalian 
development (Habets et al., 1987; Jackson et al., 1982) during which time networks 
exhibit bursts of action potentials roughly synchronized across the population. These 
synchronous population bursts are thought to be important in pruning and sculpting 
neuronal circuits during development (Tosney and Landmesser, 1985). When spinal cord 
networks were driven solely by the NMDA receptor, the activity exhibited uniquely 
periodic population bursts in which virtually every neuron participated. The temporal 
coefficients of variation (CV), reflecting the rhythmic nature of the oscillation, were 3.7, 
4.7, and 4.9 % for burst rate, burst duration, and inter-burst interval, respectively (mean 
CVs for all 16 cultures). In addition to unmasking a type of neuronal activity with 
unprecedented regularity, these experiments also demonstrate the extreme 
pharmacological manipulations that are possible with cultured networks. They provide 
clear evidence that problems in basic neurobiology can be attacked with these 
preparations. 
 
Each of the three chapters has been accepted for publication as an independent 
research report. By including them in one document, it is hoped that the utility of 
multielectrode recording in diverse areas of scientific inquiry can be more fully 
recognized. While the data presented has contributed to the body of scientific knowledge, 
the true aim of this work is to provide a reference for future experimenters desiring to 
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take advantage of multichannel recording techniques. Thus, the methods sections in each 
chapter provide guidance on the cell culture procedures necessary to grow a dependable 
supply of networks, as well as the  analysis techniques to utilize once data are generated. 
The hardware necessary to reproduce the experimental stations employed in this research 
is available from several sources. The simple experimental paradigm is the same in each 
of the studies, in that a period of control activity is compared to a period during which the 
network is under the influence of a test substance. It is hoped the information and 
examples provided will facilitate future research using cultured neuronal networks. 
 
The experience of this researcher indicates that primary neuronal culture remains 
as much an art as it is a science. Until the science becomes more exact, experimenters 
will be challenged with cultures that obstinately refuse to grow, or, if they grow, fail to 
produce reliable activity. Hopefully, the examples presented here will show that, with 
perseverance, the combination of multichannel recording and cultured neuronal networks 













ACUTE TOXICITY SCREENING OF NOVEL ACHE INHIBITORS USING 
NEURONAL NETWORKS ON MICROELECTRODE ARRAYS 
Summary 
 
Spontaneously active neuronal networks grown from embryonic murine frontal 
cortex on substrate integrated electrode arrays with 64 recording sites were used to assess 
acute neurobiological and toxic effects of a series of seven symmetrical, bifunctional 
alkylene-linked bis-thiocarbonate compounds designed to possess anticholinesterase 
activity. Acute functional neurotoxicity in the absence of cytotoxicity was defined as total 
collapse of spontaneous activity. All of the compounds were characterized as mixed 
inhibitors of AChE, with Kis  in the 10
-7-10-6 M range. The neuronal network assay 
revealed surprisingly diverse effects in response to these closely related compounds. Six 
of the seven compounds produced changes in network activity at concentrations of 10-
350 µM. Three of the compounds were excitatory, one was biphasic (excitatory, 
reversibly inhibitory), and two were irreversibly inhibitory. Responses of cortical cultures 
to eserine were compared to the effects produced by the test compounds, with only one of 
seven exhibiting a close match to the eserine profile. Matching of response patterns 
allows the classification of new drugs according to their similarity to well-characterized 
agents. Spontaneously active neuronal networks reflect the interactions of multiple 
neurotransmitter systems and can reveal unexpected side effects due to secondary 
binding. Utilizing such networks holds the promise of greater research efficiency through 




Unexpected secondary binding by compounds designed to be specific for certain 
receptors or an enzyme is a problem that affects every drug development effort. A 
reliable method for screening novel compounds for unwanted or toxic side effects could 
significantly increase the efficiency of the drug development process and minimize the 
use of experimental animals. We have used cultured neuronal networks grown from 
embryonic murine frontal cortex to assess the effects on spontaneous activity of seven 
symmetrical, bifunctional alkylene-linked bis-thiocarbonate compounds designed and 
biochemically verified to interact with both the peripheral and catalytic sites of AChE. 
Our purpose was to explore the relative efficacies of these compounds in modulating 
spontaneous activity and to utilize cultured neuronal networks as rapid screening 
platforms for determining general neurophysiological and toxic effects of novel 
compounds. 
 
The networks were grown on thin-film multielectrode arrays (MEAs) constructed 
with transparent indium-tin oxide (ITO) conductors allowing simultaneous monitoring of 
multiple neuronal spike trains and visual observation of neuronal somata and processes 
(Fig. 1.1). Such networks are spontaneously active in culture and are sensitive to 
pharmacological manipulation of the medium. This sensitivity provides an effective 
platform for rapidly assaying effects induced by known and novel neuroactive substances 
(Gross et al., 1995, 1997a,b, Morefield et al., 2000). Compounds may acutely modulate 
the activity of spontaneously active networks via several pathways. Among them are 
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receptor activation and deactivation, metabolic disturbances, modification of membrane 
characteristics, alteration of vesicular dynamics, and changes in ionic potentials. These 
effects are reflected reliably by changes in the temporal dynamics of neuron-to-neuron 

















It is evident from the literature that the cholinergic system in the CNS has a wide 
range of physiological influences. Although single cell data provide important insights 
into these domains, sequential analysis of single cell responses cannot give an accurate 
Figure 1.1: Neuronal network on recording matrix of a 64-electrode array 
plate.  The indium-tin oxide conductors are 8 µm wide and 1,200A thick.  
The polysiloxane insulation is removed by a single laser shot to form a 
recording crater the end of the conductor.  Electrolytic addition of gold 
lowers impedances to 1-2 megohms (at 1 kHz).  Higher magnifications of 
neurons from this network are shown in the inserts.  Mouse embryonic spinal 
cord; age: 52 days in vitro. (bars = 40µm) 
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picture of population response dynamics. These population responses are relatively easy 
to obtain with networks cultured on microelectrode arrays, at a cost, however, of 
disrupting the original circuitry. Nevertheless, the re-formed circuits in culture are 
pharmacologically histiotypic and demonstrate changes in spike patterns characteristic of 























Techniques used to fabricate and prepare microelectrode arrays (MEAs) have 
been described previously (Gross, 1979; Gross et al., 1985; Gross and Kowalski, 1991). 
The hydrophobic surfaces of the MEAs were activated via butane flaming through a 
stainless steel mask, followed by application of poly-D-lysine and laminin. Cortical 
tissues were harvested from embryonic 15-to-18 day gestational age Hsd:ICR mice. The 
tissue was dissociated enzymatically (papain) and mechanically, seeded on prepared 
areas of the MEAs, and maintained in Dulbecco’s Modified Minimal Essential Medium 
(DMEM) supplemented with 5% horse serum and 5% fetal calf serum in a 90% air/ 10% 
CO2 atmosphere. No antibiotics/antimitotics were used. Cultures were "fed" twice a week 
with DMEM containing 5% horse serum. Cultures maintained under these conditions can 
remain spontaneously active and pharmacologically responsive for more than six months 
(Gross, 1994).  
 
The recording medium consisted of a 50/50 mixture of fresh DMEM and 
conditioned DMEM (conditioned by culturing dissociated cortical tissue in flasks), 
supplemented with 5% horse serum. Osmolarity was adjusted to 320 mOsmoles. Eserine, 
curare and atropine (Sigma, St Louis, MO) were dissolved in sterile water. The test 
compounds were dissolved in 0.8% saline. All drugs were bath applied (bath volume 1.0-
1.5ml). Stock concentrations were prepared so that total volume added never exceeded 
1% of the total bath volume. The novel AChE inhibitors were synthesized by Vincenzo 
Talesa, University of Perugia, Perugia, Italy, and Nicholas Boyle, University of Sheffield, 
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Sheffield, England. The details of the synthesis and the AChE (purified from calf 
forebrain) inhibition analyses of the test compounds have been submitted for publication 
elsewhere (Drug Development Res.). 
 
MEAs were placed in stainless steel recording chambers (Gross and Schwalm, 
1994), and maintained at 37oC on an inverted microscope stage. The pH was stabilized at 
7.4 by passing a stream of humidified 10% CO2 (flow rate of 10-15 ml/min) in air 
through a cap featuring a heated ITO window to prevent condensation and allow 
continued observation. Neuronal activity was recorded with a two-stage, 64-channel 
amplifier system (Plexon Inc., Dallas), and digitized simultaneously via a Dell 300 MHz 
computer (spike analysis) and a Masscomp 5700 computer (burst analysis). Total system 
gain was normally 12K. The neuronal activity was discriminated with a template-
matching algorithm (Plexon Inc.) in real time to provide single unit spike rate data. 
Whole channel (multiple-units/ channel) data was analyzed using custom programs for 
burst recognition and analysis. The 16 cultures used in this study had an average 
electrode yield of 48%, and a mean signal-to-noise ratio (SNR) of 3.3:1 (including 1.5:1 
SNRs). Maximum SNRs often exceeded 10:1. Cultures were randomly assigned to 
experimental groups, with the only requirement being they were at least 21 days in vitro 
(d.i.v.) and exhibited significant spontaneous activity. No influence of culture age on 
mean levels of spontaneous activity was observed.  
 
The effects of the test compounds were interpreted in terms of two network 
activity variables, burst rate and spike rate. These variables are easily quantified, and 
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changes in mean values associated with experimental manipulations relative to a 
reference period provide reliable information on the functional state of the neuronal 
networks. The simultaneous monitoring of spike and burst rates allows detection of 
activity increases, decreases, and spike organization into bursts on a single unit basis, 
while cross-channel averaging provides information on network activity coordination. 
These relatively simple analysis techniques allow quantification of the data and easily 
visualized graphical representations of network responses to pharmacological 
compounds. 
 
All analyses were done with binned data, with a bin size of 60 seconds. Single 
unit activity was averaged across channels yielding mean network spike and burst rates. 
These quantities were graphed as a function of time, providing a picture of the temporal 
evolution of activity and allowing a determination of stationary activity states (variations 
in burst and spike rates of  <15%). An experimental episode mean was obtained from the 
values comprising the stationary state. Control periods were always 30 min., whereas 
experimental episodes ranged from 20-30 min. because of exclusion of the transition 
states. Within single experiments, significance of changes induced by drug application 
was tested with a paired Student's t test, with p<0.05 accepted as significant. For pooled 
data (Figure 1.2d and 1.3), significance was tested with a one-way ANOVA followed by 







The responses of frontal cortex cultures to a series of cholinergic agonists, 
antagonists, and the well-characterized AChE inhibitor eserine, were determined in order 
to demonstrate that these cultures were suitable assay vehicles for the series of novel 
AChE blockers. Figure 1.2a illustrates the results of applying curare (15 µM), an 
antagonist at nicotinic receptors containing the α7 subunit. An increase in both bursting 
and spiking occured within seven minutes and persisted until the end of the experiment. 
Figure 1.2b shows the response to an application of the non-specific muscarinic 
antagonist, atropine.  Both burst and spike rates are depressed below reference period 
levels, (28% and 32% respectively). This depression lasted until the end of the recording. 
Under conditions of spontaneous activity, antagonists were especially effective in 
revealing functional cholinergic synapses.  
 
Figure 1.2c shows a network in which 30 µM bicuculline, the GABAA antagonist, 
was applied at the beginning of recording, followed by application of 30µM carbachol at 
190 minutes. The network response shows a near doubling of burst and spike rates that 
persist for the duration of the experiment. The bicuculline-carbachol effect could be 
antagonized by application of 20 µM atropine (not shown). The major potentiation of 
activity is reminiscent of the well-known effects of carbachol in producing epileptiform 




Figure 1.2d summarizes the results from 4 experiments in which eserine, a well-
characterized inhibitor of AChE, was titrated from 10 to 150 µM. The mean response is 
biphasic, with eserine increasing both bursting and spiking at 10 and 25 µM and 
inhibiting activity at concentrations above 50 µM. The inhibition of activity by eserine 
was reversible by washing (not shown). Together, these data indicate that the frontal 
cortex cultures used here possess both curare-sensitive nicotinic and atropine-sensitive 
muscarinic cholinergic receptors. Additionally, functional cholinergic synapses mediate a 
tonic inhibition of activity through nicotinic receptors concomitant with a tonic excitation 
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Averaged (n=4) cortical network responses to eserine (Fig. 1.2d) were used to 
define a response profile to this known AChE inhibitor. Main features of this profile 
include an initial excitation at lower concentrations (10-40 µM), followed by a 
suppression of activity at concentrations beyond 40 µM, with almost total inhibition of 
bursting and spiking at 150µM. The effects were reversible with one or two complete 
medium exchanges. This profile served as a reference for the novel AChE inhibitors. 
 
For testing the novel AChE inhibitors, which were identified as pure with TLC, 
1H NMR, and FTIR spectrophotometry by Nicholas Boyle, 16 murine frontal cortex 
cultures were used. The median age of the networks was 27 days in vitro, with a 
minimum of 21 and a maximum of 41 days. Cultures stabilize 3 weeks after seeding and 
do not change their pharmacological responses for up to 4-6 months (Gross et al., 1997a). 
Table 1 lists the structure and AChE inhibition constant of each compound.  
Figure 1.2: Response of frontal cortex cultures to well characterized agents affecting 
cholinergic neurotransmission. a) Application of the nicotinic receptor antagonist curare (15 
µM) induced an increase in burst and spike rates. b) The non-specific muscarinic receptor 
antagonist atropine (15 µM) produced an inhibition of bursting and spiking. c) Application of 
carbachol 30 min after bicuculline produced large increases in the burst and spike rate 
activity. This effect persisted for the duration of the experiment. d) Mean responses of 4 
experiments to titration of the acetylcholinesterase inhibitor eserine (10-150 µM). At low 
concentrations, eserine produced an increase in both burst and spike rates. The excitation was 
reversed by increasing concentrations, resulting in an average 95% suppression of burst rates 
and an average 90% inhibition of spike rates at 150 µM. The effects produced by eserine were 





The network activity changes induced by the novel compounds were grouped into 
two categories, Excitatory and Inhibitory. These categories were further subdivided into 
Reversible (R), Irreversible (I), and Partially Reversible (P). Reversibility was defined as 
a return to near reference activity (< 20% change) after one to two complete medium 
changes. Partial reversibility represented recovery of activity after washing that deviated 
more than 20% from control period. Partial reversibility was not encountered in this data 
set. An effect was considered irreversible if there was no return of any activity after two 
or more complete medium changes and a subsequent wait of at least 2hr. Table 2 
summarizes the structure, minimum effective concentration, and type of effect for each of 
the compounds. 
 
TABLE 1: LIST OF TEST COMPOUNDS 
 
 INHIBITOR         STRUCTURE                   AChE INHIBITION          INHIBITION
      CONSTANTS, Ki (M)  TYPE 
 
     I1         Ch+O-CO-S(CH2)2S-CO-OCh+               1.0x10-6                      Mixed 
   
     I2         Ch+O-CO-S(CH2)3S-CO-OCh+               1.4x10-6                          Mixed 
 
     I3         Ch+O-CO-S(CH2)4S-CO-OCh+               1.0x10-6                               Mixed 
 
     I4         Ch+O-CO-S(CH2)5S-CO-OCh+               1.4x10-6                       Mixed 
 
     I5         Ch+O-CO-S(CH2)6S-CO-OCh+               1.4x10-6                  Mixed 
 
     I6         DMEA+O-CO-S(CH2)4S-CO-DMEA+              3.6x10-7                   Mixed        
 
     I7         DMEA+O-CO-S(CH2)6S-CO-DMEA+ 5.0x10-7     Mixed 
  




The results from application of novel AChE inhibitors to frontal cortex networks 
are summarized with dose-response graphs in Fig. 1.3. It is apparent that minor molecular 
differences in the structures of the inhibitors can have profound effects on the changes in 
network activity. Two compounds, I1 and I3, caused increases in bursting, with little 
effect on spike rates, but I3 was significantly more potent in its effects. Two of the 
compounds, I5 and I7, irreversibly inhibited network activity at relatively high 
concentrations. One compound, I6, increased activity at low concentrations, but 
reversibly inhibited bursting and spiking when the concentration was increased. Another 
compound (I4), elicited little effect on network activity at concentrations to 0.5 mM. 
Inhibitor 2 increased spiking activity, while simultaneously lowering the burst rate, 
reflecting changes in the organization of network spike activity. It is of interest that the 
three cultures used in assaying the effects of I2 were 23, 28, and 37 d.i.v. An examination 
of the standard error bars in the graph for I2 in Fig. 1.3 shows responses of the networks 
were not affected by age differences in any significant way. 
TABLE 2: NETWORK RESPONSES TO TEST COMPOUNDS 
 
INHIBITOR    SPACER    BASE       EXCITATORY  INHIBITORY   REVERSIBILITY       n 
              [mM]                       [mM]     
 
I1                2C  choline  10                R           2 
I2             3C  choline  50                      R           3 
I3             4C  choline  10               R           2 
I4             5C  choline  NE     NE             --           2 
I5             6C  choline    350              I                     2 
I6             4C  ethanolamine      25         125              R                     3  
I7             6C  ethanolamine   200              I           2 
 
n= # of cultures tested 
R= reversible after one or two medium exchanges 
I= irreversible after two or more medium exchanges and at least a two hour wait 

































































































































































Figure 1.3: Dose-response summary for eserine and seven novel anticholinesterases 
using the network activity variables burst rate and spike rate. Percent change was 
calculated for a 20-30 minute window of activity at the concentration listed (see 
Methods section), relative to a 30-minute reference period of spontaneous activity. 
Data shown represents mean of two, or in the case of Inhibitors 2 and 6, three 
experiments. Eserine data originates from four experiments. Vertical bars represent 
the range of responses for inhibitors 1,3,4,5,7, (n=2) and standard error for inhibitors 
2, 6, and eserine. I1 increased burst rate at 10µM eliciting a maximal increase of 
74% at 100µM. The compound did not change spike rates significantly at any 
concentration tested. I2 increased spike rates at 100µM and above with a 
concomitant inhibition of bursting. I3 was the most efficacious of the compounds, 
increasing burst rates an average of  98% above baseline at 25µM. I3 was ineffective 
at altering spike rates in the range shown, and at concentrations up to 0.5mM (data 
not shown). I4 was the least effective agent tested, producing a 27% inhibition of 
burst rate only at concentrations of 0.5mM. I5 produced a slight increase in both 
bursting and spiking at 50-200µM, which was transformed into a 79% and 84% 
inhibition of burst and spike rates, respectively, at 350µM. This inhibition could not 
be reversed by washing. I6 produced a biphasic effect, increasing both bursting and 
spiking significantly at 25-50µM, and reversibly inhibiting both parameters at 
concentrations above 75µM.  I7 produced effects very similar to I5, although it was 
more potent, with an irreversible inhibition of both bursting and spiking at 
concentrations above 150µM. Response to eserine was biphasic, with excitation of 
burst and spike rates occurring at the 10 and 25µM concentrations, and inhibition of 
both activity measures occurring at 75µM and above. The suppression of activity by 
eserine was reversible. * indicates significant difference from control period, 














Figure 1.4 provides an alternative view of the data presented in Fig. 1.3 for the 
seven novel AChE inhibitors. The bars make the biphasic nature of the network responses 
more apparent for I5 and I6, and offer a better look at the opposing effects on network 



















































































































































Figure 1.5 illustrates the effect of I5, a choline-based compound with a 6-carbon, 
hexylene spacer. I5 produced small increases in burst and spike rates at 10-200 µM but 
produced an irreversible inhibition of activity at 350 µM. However, monitoring of the 
network for a 12-hour period through an inverted microscope and video display showed 
no visually discernible cytotoxicity associated with the loss of activity. No activity was 




Figure 1.4: Summary of effects of novel anticholinesterases on network activity 
variables burst rate and spike rate. Percent change was calculated for a 20-30 minute 
window of activity at the concentration listed, relative to a 30-minute reference 
period of spontaneous activity. Data shown represents mean of two, or in the case of 
Inhibitors 2 and 6, three experiments. Vertical bars represent the range of responses 
for inhibitors 1,3,4,5,7, and the SD for inhibitors 2 and 6. Inhibitor 1 increased burst 
rate at 10µM, eliciting a maximal increase of 74% at 100µM. The compound did not 
change spike rates significantly at any concentration tested. Inhibitor 2 increased 
spike rates at 100µM and above with a concomitant inhibition of bursting. I3 was the 
most efficacious of the compounds at increasing burst rate, with a 98% increase 
above baseline occurring at 25µM. Inhibitor 4 was the least effective agent tested, 
producing a 27% inhibition of burst rate only at concentrations of 0.5mM. I5 
produced a slight increase in both bursting and spiking at 50-200µM, which was 
transformed into a 79% and 84% inhibition of burst and spike rates, respectively, at 
350µM. This inhibition was not reversed by washing. I6 produced a biphasic effect, 
increasing both bursting and spiking significantly at 25-50µM, and inhibiting both 
parameters at concentrations above 75µM. The inhibitory effects of I6 were 
reversible. Inhibitor 7 produced effects very similar to I5, although it was more 




















Inhibitor 6, a DMEA-based compound, produced a biphasic effect on network 
activity (Fig. 1.6). At 25 µM, I6 caused increased spike production greater than 90%. 
Burst rate was increased by 80% at the same concentration. Increasing the concentration 
to 50 µM resulted in a spike rate increase averaging 101%, with a concomitant increase 
in burst rates of 73%. The excitatory window for I6 was rather narrow; at 75 µM the 
spike rate was inhibited by 28% while burst rates were 29% below baseline. Maximal 







































Figure 1.5: Irreversible inhibition of network activity in response to I5. (A) Mean 
+/- SD of 28 discriminated units. Titration to 200µM produced very little effect on 
spike rates, raising the concentration to 350µM caused a rapid reduction in spiking. 
All spike activity was abolished within approximately 30 min. (B) The effect on 
spike rates was paralleled by burst rate inhibition (mean+/-SD of 12 channels). 
However the standard deviation of the burst rates began to increase at 50µM, 
indicating a lessened cross-channel coordination. The inhibition was not reversible 




above. The burst rate was reduced to zero by concentrations exceeding 100 µM. The 
inhibition of network activity was reversible by washing, in contrast to that produced by 











The other DMEA-based compound, Inhibitor 7, produced only inhibitory effects 
on network activity, suppressing spike and burst rates at 150 µM by an average of 50% 
and 43% respectively. I7 totally stopped all activity at 200 µM (Fig. 1.7). This effect was 
irreversible with only transient activity recovery after 2 complete medium changes, 
followed by a complete cessation of activity for a 3-hour observation period. There was 
no overt cytotoxicity associated with this functional (electrophysiological) toxicity. 
Neuronal somata remained phase-bright, without cytoplasmic granularity throughout the 










































Figure 1.6: With a 4C 
spacer and a DMEA 
residue, I6 had a 
biphasic effect on 
spiking and bursting, 
increasing both activity 
measures at 
concentrations of 25-50 
µM. This activity 
increase was reversed at 
concentrations of 75 µM 
and above. Only minor 
spiking remained at 125  
µM. The inhibitory 
effect was reversible by 
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Figure 1.7: Inhibitor 7 (DMEA-based compound with a hexylene spacer) caused only 
moderate increases in the standard deviation of the burst rate, until the concentration 
was increased to 150µM, at which point the burst rate was depressed. At 200µM, 
Inhibitor 7 totally suppressed all network activity. The inhibition was not reversed by 




We tested the responses of murine frontal cortex networks cultured on 
multielectrode arrays to seven newly synthesized compounds designed to block AChE, 
the primary effector of ACh removal from the synaptic cleft. The presence of this enzyme 
in the cortical cultures was deduced from the change in activity elicited by eserine, a 
specific blocker of AChE. Eserine was effective in increasing network activity at a 
concentration range of 10-25 µM, while it suppressed network activity at higher 
concentrations. This biphasic activity of eserine has been seen at the neuromuscular 
junction at which eserine at low concentrations (1-20 µM) increased the amplitude and 
prolonged the decay time of endplate-currents but, at 20 µM to 2 mM, decreased the 
decay times (Dudel et al., 1999). The 1-20 µM effects were attributed to inhibition of 
AChE, while the high dose effects were thought to be a result of a direct blocking action 
of eserine on the open channel configuration of the nicotinic receptor. Blocking of 
nicotinic ACh receptors by eserine and 4 other AChE inhibitors was also seen by van den 
Beukel et al. (1998) in a variety of cell types.  In the feline medulla, chemosensitive 
respiratory neurons also responded biphasically to eserine, with an initial augmentation of 
neuronal activity at low concentrations that converted to a depression in firing rates at 
higher concentrations in an apparently opioid-receptor dependent fashion (Trouth et al., 
1993). 
 
Although eserine is approved for clinical applications in the treatment of 
Alzheimer's, the therapeutic window for this drug is relatively narrow. This is also the 
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case for I6, the novel compound that most closely resembled eserine in its effects. 
Possible therapeutic windows are wider for compounds I2 and I3, which demonstrate 
increases in spike production and burst production respectively. Although they show no 
general inhibition, the compounds affect spontaneous activity differently. Whereas I2 
transforms bursting into spiking, I3 is very effective at organizing existing spikes into 
bursts. As increased bursting generally is associated with epileptiform activity, I3 may 
indeed trigger epilepsy, whereas I2 may stabilize epileptic tissue. Animal experiments 
clearly are required to determine the final behavioral response. However, the dose-
response curves of Figure 3 provide valuable data that can be used to increase the 
efficiency of drug screening procedures. The irreversible inhibitory effects of I5 and I7 
would seem to make them unsuitable for possible clinical applications. Such inhibition of 
network activity should be considered acute, functional toxicity despite a lack of 
cytotoxicity. Tetrodotoxin would be a compound in this category. 
 
Cholinergic neurons intrinsic to the frontal cortex have been labeled 
immunohistochemically with antibodies to the vesicular acetylcholine transporter 
(Arvidsson et al., 1997) and choline acetyltransferase (ChAT) (Johnston et al., 1981). 
Cossette et al. (1993) demonstrated that ChAT activity recovered to near normal levels in 
the fronto-parietal cortex within three months of ibotenic acid lesion of the nucleus 
basalis in adult rats. These results, along with the effects of eserine that we observed, 
imply that cholinergic neurons are intrinsic to the cortex of intact animals and that these 
neurons survive in our cultures and make functional synapses. 
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It is interesting to compare the effects on neuronal activity of the seven 
compounds with their inhibition of AChE (Tables 1 and 2). All the test compounds were 
classified as giving mixed inhibition, although double reciprocal plots suggest inhibition 
of a non-competitive nature. This phenomenon has been addressed by others, who 
contend that certain types of AChE inhibitors exhibit mixed inhibition (Krupka, et al., 
1961).  From Table1, it can be argued that the DMEA derivatives (compounds 6 and 7), 
are better AChE inhibitors than the choline derivatives, (compounds 1-5). The former 
have Ki values in the 10
-7M range, while the latter derivatives have Ki values in the 10
-6M 
range. Further, there is no apparent relationship between alkylene length separating the 
thiocarbonate moieties and the inhibitory potencies of the choline or the DMEA 
derivatives. This also suggests that inhibitory potencies of the compounds are not 
dependent upon binding with both the peripheral binding site and the active site of AChE, 
since the greater the separation between the thiocarbonate moieties the greater the 
anticipated binding with both sites (Pang et al., 1996).  
 
 
For the choline-containing compounds, Table 2 shows that there is an apparent 
relationship between alkylene length and increase or inhibition of the spontaneous 
network activity. With linker chains having two to five carbon atoms (compounds 1-4), 
no inhibitory action is found, but excitatory activity does occur with demonstrated 
reversibility. The one exception is compound I4 (5-C spacer), which shows neither 
excitatory nor inhibitory activity and apparently is in a transitory position between 
excitatory and inhibitory behavior. When the choline-bearing bis-thiocarbonate has a 
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spacer length of 6 carbon atoms (compound 5), all excitatory activity is lost and 
irreversible inhibition of spontaneous network activity occurs. The reversible and 
irreversible cessation of network activity in response to three of the seven compounds 
could not be anticipated from the biochemical data. The fact that two of these compounds 
are irreversibly toxic is surprising and emphasizes the importance of tissue-based 
screening early in the drug development process. 
 
For the better AChE inhibitors, the DMEA derivatives, Table 2 shows that 
compound I6 (4-C spacer) demonstrates both reversible excitatory and reversible 
inhibitory effects on neuronal networks. This contrasts with the activity of choline-
containing compound I3 (4-C spacer), which has only reversible excitatory activity. The 
DMEA-containing compound 7 (6-C spacer) has only irreversible inhibitory effects, 
similar to that of the choline-containing compound 5 (6-C spacer). A logical conclusion 
from these data is that the effects of the inhibitory bis-thiocarbonates on the neuronal 
networks reflect varying combinations of their actions on AChE activity and their 
unexpected interaction with neuronal ionotropic receptor sites. 
 
Acetylcholine in the frontal cortex is primarily a neuromodulator that has been 
implicated in arousal, attention, learning and memory. The effects of ACh are exerted 
pre- and post-synaptically and have been shown to regulate release of neurotransmitters 
and post-synaptic excitability (McGehee and Role, 1996). The therapeutic strategy of 
increasing cholinergic activity by inhibiting the enzymatic hydrolysis of ACh, thereby 
increasing the constitutive amount of neurotransmitter available, can have multiple 
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outcomes depending upon the receptor subsequently activated. Increased ACh levels that 
result in an activation of certain presynaptic nicotinic receptors, such as the α7 and α4β2 
subtypes, could lead to increased release of ACh from the cell stimulated, especially in 
conditions of impaired cholinergic function as exists in Alzheimers (Marchi and Raiteri, 
1996). On the other hand, increasing the activation of presynaptic m2 muscarinic 
receptors could result in lower levels of ACh release (Vizi et al., 1989; Rouse et al., 
1997). Such antagonistic responses make it difficult to predict physiological effects from 
biochemical or even single cell data. However, a spontaneously active network reflects 
the interactions of all transmitter systems present. The use of such networks as an 
intermediate step between biochemical analyses and animal experiments holds the 
promise of greater research efficiency through a rapid recognition and quantification of 













Additional Considerations for the Use of Cultured Neuronal Networks  
in Pharmacology 
 
This work demonstrates the utility of neuronal networks in testing novel drug 
candidates that can affect neural activity. The compounds described had a known 
biochemical effect, the inhibition of AChE. However, the biochemical assay examines 
only one aspect of a drug. The neuronal networks consist of living cells expressing a wide 
variety of neurotransmitter receptors, ion channels, and transport proteins on the surface 
of their plasma membranes. There are continual intracellular biochemical processes, the 
sum of which produces a characteristic behavior that can be monitored optically and 
electrically. Novel drugs potentially can interact at any of these points, producing 
changes in neuronal activity that cannot be predicted from the biochemical activity of the 
drug.  
 
Thus, neuronal networks, when used in a drug development environment, can 
provide valuable information that may be used to guide the drug developer in 
discriminating between molecules that are potentially acceptable for further testing and 
those that produce neurotoxicity or changes in network activity not representative of the 
known biochemical effects. Implementation of neuronal network screening of novel 
drugs as a standard methodology could offer large cost savings to pharmaceutical 
companies, by allowing the drug development effort to focus on candidate compounds 
that possess both a desired biochemical activity and effects on neuronal interactions that 
are compatible with that activity. Most important, such screening can provide information 
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on undesired binding or interactions that are extremely difficult to discover with purely 
biochemical assays and are expensive to elucidate in whole-animal experiments. 
 
Additional information can be gained from the neuronal networks. As shown 
here, titration of drugs can produce reliable dose-response curves. These curves may be 
used to compare the effects of different compounds that putatively interact at the same 
binding site, allowing characterization of drugs by rank order potency. Rank order 
potencies can give a qualitative estimate of the selectivity of the binding site for different 
compounds. A quantitative evaluation of selectivity may be gathered by the use of 
potency ratios. The ratio of the EC50s for two compounds is related linearly to the relative 
binding strengths of the compounds at a specific site.  
 
Determination of the binding strengths for agonists (1/KdA) at specific receptors 
is possible if a specific irreversible antagonist is available. Constructing dose response 
curves in the absence and in the presence of increasing concentrations of the antagonist 
will allow comparison of the concentration of agonist required to elicit equal functional 
responses as the antagonist concentration is increased. The KdA may be determined from 
a plot of the agonist concentrations in the presence of the antagonist against the ratio of 
the agonist concentration in the presence of the antagonist ([A']) to the agonist 
concentration in the absence of the antagonist ([A]). 
 
The binding strength of reversible antagonists (KdB) may be found by 
constructing dose response curves for an agonist effect as the concentration of the 
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antagonist is increased. The values for the EC50 of the agonist at different concentrations 
of antagonist may be used to find a dose ratio. This number is the ratio of the EC50 with 
antagonist to the EC50 without antagonist ([A']/[A]). A plot of log (([A']/ [A])-1) against 
the log of the concentration of antagonist is called a Schild plot. The intercept of a line 
fitted to the data with the X-axis is the Kd of the antagonist.  
 
Determination of binding strengths using neuronal networks is susceptible to 
several problems. A particular response is elicited by a unique concentration of drug at a 
binding site. Therefore, maintenance of drug concentrations at a constant level at the 
receptor of interest is necessary. Factors influencing the equilibrium of the drug 
concentration include chemical degradation of the drug during the experimental episode, 
enzymatic degradation by the neuronal tissue, non-specific binding, and uptake of the 
drug by the tissue. Experiments done with the novel AChE inhibitors utilized bath 
application of the test compound into a volume of 1-2 ml. This should provide what is 
essentially an infinite reservoir of drug, compared to the volume of tissue. However, 
chemical degradation still can occur and complicate interpretation of neuronal network 
responses.  
 
Neuronal networks consist of multiple interacting cell types expressing a wide 
variety of receptors. The accurate determination of binding strengths is dependent upon 
the measured response being mediated by a single receptor type. This may be possible if 
other drugs are used to block effects not specific to the receptor of interest. Knowledge of 
the drug mechanism and the ability to isolate the effect elicited by that mechanism either 
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pharmacologically or with suitable control experiments is a prerequisite. Quantification 
of the drug effect should be at a point where network activity has reached a stationary 
state. Drug applications often elicit responses that vary over time, with some compounds 
requiring several minutes to reach the full effect.  Conversely, sometimes there is a 
recovery from the maximal effect a compound produces. This may represent mechanisms 
such as desensitization or internalization of the receptor, or homeostatic regulation of 
neuronal excitability that may occur on several time scales.  
 
The primary goal for implementing large-scale pharmacological testing must 
become delineation of the response reliability of the neuronal networks to a wide range of 
known pharmacological compounds. This validation of the system is essential before 
testing of unknown drug candidates can be undertaken. The concomitant development of 
software to enable real-time multi-variate analysis of the large data streams inherent in 
the multi-channel environment will provide the tools necessary to ensure that neuronal 



















CHARACTERIZATION OF ACUTE NEUROTOXIC EFFECTS 
OF TRIMETHYLOLPROPANE PHOSPHATE VIA  
NEURONAL NETWORK BIOSENSORS 
Summary 
 
We have utilized cultured neuronal networks grown on microelectrode arrays to 
demonstrate rapid, reliable detection of a toxic compound, trimethylolpropane phosphate 
(TMPP).  Initial experiments, which were performed blind, demonstrated rapid 
classification of the compound as a convulsant, a finding consistent with previous whole 
animal neurobehavioral studies.  TMPP (2-200 µM) reorganized network spike activity 
into synchronous, quasi-periodic burst episodes.  Integrated burst amplitudes invariably 
increased, reflecting higher spike frequencies within each burst.  The variability of 
network burst parameters, quantified as coefficients of variation (CVs), was decreased.  
Mean CVs for burst duration, interburst interval, and burst rate were lowered by 42 ± 13, 
58 ± 5.5, and 62 ± 1.8%, respectively (mean ± SEM, n=8 cultures, 197 channels). These 
changes in network activity paralleled the effects induced by bicuculline, a known 
disinhibitory and seizure-inducing drug, and confirmed classification of TMPP as a 
potential epileptogenic compound. Simple pharmacological tests permit exploration of 
mechanisms underlying observed activity shifts. The EC50 for GABA inhibition of 
network activity was increased from 2.8 to 7.0 µM by 20 µM TMPP and to 20.5 µM by 
200 µM TMPP.  Parallel dose response curves suggest that TMPP acts by a competitive 
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antagonism of GABA inhibition and are consistent with reported patch-clamp analysis of 
TMPP-induced reduction of inhibitory postsynaptic current amplitudes.  The potency of 
TMPP in generating epileptiform activity in vitro was comparable to concentrations 
reported for in vivo studies. TMPP and bicuculline produced both increases and decreases 
in burst rate, depending on native spontaneous bursting levels.  These results demonstrate 
a need for multivariate analysis of network activity changes to yield accurate predictions 


















 The ability to detect compounds with the capacity to affect neurophysiologic 
function is a major concern to civilian and military communities.  Neuroactive 
compounds can alter performance and behavior of organisms in many different ways; 
from life-threatening catastrophic failure of organ systems that rely on neural input to 
subtle, but debilitating, changes in cognitive processes and motor coordination.  
Neuroactive compounds include neurotoxins, several of which are considered potential 
biological weapons, as well as neurotoxicants, where a risk may arise via environmental 
or occupational exposure.  One such neurotoxicant, trimethylolpropane phosphate 
(TMPP), is an ethyl bicyclophosphate convulsant produced during the partial pyrolysis of 
certain synthetic, ester-based turbine lubricants supplemented with phosphate-based 
lubricity additives (Toia and Casida, 1987; Centers, 1992; Wyman et l., 1987).  Over the 
course of several years, it has been shown that acute exposure of rats to TMPP [0.05-1.0 
mg/kg, intraperitoneal (ip)] induces electroencephalographic paroxysms, stereotypic 
behaviors, sub-clinical seizures, clinical convulsions, status epilepticus, or lethality in a 
dose-dependent manner (Bellet and Casida, 1973; Wyman et al., 1993; Lindsey et al., 
1998).  While there are no documented cases of human exposure to TMPP, it constitutes 
a potential human risk of dermal or inhalation exposure consequent to fires aboard 
military ships or both military and commercial aircraft (Wyman et al., 1987; Wyman et 
al., 1993).  
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 Given the diversity of potential threats to neurophysiologic function, there is a 
need for sensor systems that rely on physiologic endpoints for detection.  Moreover, the 
rapid introduction of new compounds by chemical and pharmaceutical industries, as well 
as academia, presents a significant challenge to neurotoxicologic screening efforts.  To 
supplement current methods, which primarily rely on animal neurobehavioral testing, in 
vitro test systems using either cell lines or high-yield primary cell cultures, are receiving 
increased attention.  Data accumulated so far indicates that in vitro systems are well 
suited for rapid, inexpensive, and quantitative screening of toxicants under highly 
controlled experimental conditions.   
 
 Recent advances in growing nerve cell networks on substrate-integrated, thin-film 
microelectrode arrays in cell culture have led to experimental systems in which the 
spontaneous electrical activity can be monitored by 32 to 64 electrodes for periods of 
time reaching several months (Gross, 1994).  The large number of electrodes and stable 
cell-electrode coupling provide massive data on the internal dynamics of these nerve cell 
networks.  These systems are accessible pharmacologically and have shown both a high 
sensitivity to neuroactive/toxic compounds and tissue-specific responses, i.e., the cultured 
networks share the profiles of pharmacological sensitivity of the parent tissue (Gross et 
al., 1997; Gramowski et al., 2000; Morefield et al., 2000).  Clearly, subtle aspects of 
information processing, which are more dependent on circuit structure, cannot be 
duplicated in culture.  Nevertheless, pharmacological responses are robust and highly 
reproducible (Gross and Kowalski, 1991; Gross et al., 1992; Gross, 1994; Rhoades and 
Gross, 1994; Gross et al., 1997).  Such networks offer new assay and sensing systems 
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that lie between biochemistry and whole animal experiments and provide rapid, 
quantitative information on neurophysiological responses to chemicals.  
  
 TMPP originally was provided to the Center for Network Neuroscience at UNT as 
an unknown test substance.  The compound was quickly identified as a potential 
convulsant, since it mimicked responses obtained with the GABAA antagonist 
bicuculline.  With present equipment and methodologies, such a classification could be 
made in 10 to 30 min, depending on substance concentration.  A reliable warning of 
potential debilitating neural changes often can be obtained in less than 3 min.  This paper 
describes subsequent experiments designed to quantify acute neurophysiological effects 
of TMPP on spontaneously active primary neuronal cultures growing on substrate 
integrated microelectrode arrays.  It aims to demonstrate that such systems can provide 
rapid, reliable warning of the presence of toxic substances and, from the manner in which 
the spontaneous activity changes, can provide information on the class of compound 
present and its potential physiological effects.  This paper also demonstrates that simple 
pharmacological tests can provide valuable information on primary mechanisms involved 










Techniques used to fabricate and prepare microelectrode arrays (MEAs) have 
been previously described (Gross, 1979; Gross et al., 1985; Gross and Kowalski, 1991).  
The hydrophobic surfaces of MEAs were activated by butane flaming through a stainless 
steel mask, followed by application of poly-D-lysine and laminin.  Spinal and cortical 
tissues were harvested, respectively, from embryonic 14-15 and 16-18 day gestational 
age Hsd:ICR mice.  The tissue was dissociated enzymatically (papain) and mechanically, 
seeded on the prepared areas of the MEAs, and maintained in either Minimum Essential 
Medium supplemented with 10% horse serum (MEM-10 for spinal cultures), or 
Dulbecco’s Modified Minimal Essential Medium (DMEM) supplemented with 5% horse 
serum (for frontal cortex cultures), in a 90% air and 10% CO2 atmosphere at 37
o C. No 
antibiotics/ antimitotics were used.  Cultures were "fed" twice a week with 50% medium 
changes.  Cultures maintained under these conditions can remain spontaneously active 
and pharmacologically responsive for more than six months (Gross, 1994).  Figure 2.1 
shows a typical research work station comprised of a Plexon MNAP system with two 
monitors (A) and recording chambers developed and fabricated by the CNNS (B).  Fig. 
2.1C depicts a monolayer network growing on an array of 64 ITO electrodes. 
 
MEAs were placed in stainless steel recording chambers (Gross and Schwalm, 
1994), and maintained at 37oC on an inverted microscope stage (Fig. 2.1).  The pH was 
stabilized at 7.4 by passing a stream of humidified 10% CO2 (flow rate of 10-15 ml/min) 
in air through a cap featuring an ITO window heated to prevent condensation and thus 
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allow continual microscope observation.  Neuronal activity was recorded with a two-
stage, 64-channel amplifier system (Plexon Inc., Dallas, TX), and digitized 
simultaneously via a Dell 300 MHz computer (spike analysis) and a Masscomp 5700 
computer (burst analysis).  Total system gain used was typically 12,000.  The neuronal 
activity was discriminated with a template-matching algorithm (Plexon Inc.) in real time 
to provide single unit spike rate data.  Whole channel (multiple-units/channel) data was 
analyzed using custom programs for burst recognition and analysis.   
 
The recording medium consisted of a 50/50 mixture of fresh DMEM or MEM and 
medium conditioned by culturing the respective tissues in flasks.  Osmolarity was 
adjusted to 320 mOsmoles.  TMPP was generously provided by the Naval Health 
Research Center/Toxicology Detachment (Wright Patterson Air Force Base, OH).  All 
drugs were applied to a constant volume medium bath (1.0 or 2 ml).  Stock 
concentrations were prepared so that sample volumes added never exceeded 2% of the 
total bath volume.   
 
The experiments described lasted for several hours and, in some cases, for several 
days.  During these experimental periods it was necessary to follow the evolution of 
activity with time and in response to test substances.  We found bins of one minute to be 
adequate temporal windows for summarizing vast multichannel data without substantial 
phase delay.  In these bins, activity variables such as spike and burst production remain 
numbers, whereas other variables such as burst duration, period, and integrated amplitude 
are averaged and form "minute means".  Single unit activity per minute was averaged 
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across channels yielding mean network activity variables.  These quantities were graphed 
as a function of time, providing a picture of the temporal evolution of activity and 
allowing a determination of stationary activity states (variations in burst and spike rates 
of <15%).  An experimental episode mean was obtained from the minute values 
comprising the time period from the addition of a pharmacological substance to the next 
manipulation (wash or TMPP concentration increase).  Control periods always were 
greater than 30 min., whereas experimental episodes ranged from 20-40 min.  Withi  
single experiments, significance of changes induced by drug application was tested with a 
paired Student's t-test, with p<0.05 accepted as significant.  For pooled data, significance 
was tested with a one-way ANOVA followed by a post hoc Dunnett's test, p<0.05.   
 
To derive bursts from spike data, the analog channel output was integrated, after 
rectification and filtering with low pass RC circuits with time constants of 50 ms. For 
display on chart recorders, pen inertia increased the time constant to approximately 200 
ms. Fig. 2.2 shows whole channel, non-discriminated spike trains and the corresponding 
integrated profiles reflecting bursts.  Such profiles allow a simple quantification of burst 
periods, durations, and burst amplitudes.  The latter are influenced by the number of units 
recorded by an electrode, the spike amplitude, and the spike frequency in bursts.  
However, when the first two variables are constant (which is normally the case), the spike 
frequency dominates.  This situation becomes simpler after spike discrimination in which 
the integrated profile represents only one selected unit.  Clearly, toxic substances can 
change activity patterns as well as spike amplitudes and shapes, and a simultaneous 
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Figure 2.1.  Experimental workstation.  (A) Faraday cage with inverted microscope 
and culture life support accessories including DC power supplies for heating and gas 
metering equipment for providing 10% CO2 in humidified air at 15 ml/min to maintain 
pH of the culture at 7.4.  Oscilloscopes and two monitoring screens display data 
digitized by the Plexon multichannel data amplification and processing system. (B) 
recording chamber on microscope stage with Plexon preamplifiers attached.  A cap 
with a heated window covers the medium bath and maintains a10% CO2 atmosphere 
while allowing continual microscope observations.  (C) Neuronal network on 
recording matrix of a 64-electrode array plate. Mouse embryonic spinal cord; age: 52 



























Figure 2.2  Analog integration of spike trains from all active units recorded by a 
single electrode.  (A) Raw data displayed on oscilloscope, (B) the same data 
integrated with a time constant of 70 ms and displayed on chart recorder.  Pen inertia 
increases the time constant to approximately 200 ms.   Note the frequency 
dependence of integration, which responds only to bursts and ignores single spikes.  
Bar: 1 sec; ba: integrated burst amplitude; bd: burst duration; ibi: interburst interval.  
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Results 
General Network Responses to TMPP 
 
  TMPP was evaluated initially as an unknown sample to determine the extent that 
the neuronal network sensor paradigm could be used for rapid classification of this 
neurotoxicant. Under control conditions, spontaneous activity from neuronal networks 
combined phasic and tonic spiking with bursts of variable durations into complex 
temporal patterns. Spikes were typically biphasic with duration of 0.5 to 1.0 ms and 
amplitude ranging from 200-1200 µV. Typical spontaneous baseline burst rates, averaged 
across the units recorded, ranged from 2-30 bursts per minute (bpm) and burst durations 
ranged from 80-300 ms (Fig.2.3A). Application of a low concentration of the unknown 
sample (2 µM) revealed an increase in the percentage of spikes found in bursts or by 
triggering bursting, if it is not present during the native spontaneous activity (Fig. 2.3B).  
In addition, the compound decreased the temporal variability of burst variables such as 
burst rate, burst duration, burst period, and integrated burst amplitude, and synchronized 
bursts on all channels.  TMPP effects appeared to be “global”, i.e. all monitored channels 
exhibited a similar response.  At 2 µM, all channels reflected a reduction in the 
complexity of burst durations, and most channels showed an increase in burst amplitudes 
that, however, still revealed fluctuation in magnitude.  At 100 µM TMPP, a substantial 
increase in burst amplitudes was observed, together with a remarkable decrease in the 
variability of amplitudes, burst rates, and burst durations (Fig. 2.3C & 2.3D).  In this 
instance the response was more rapid (approximately 2 min), and regularization of burst 
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amplitude was immediately apparent.  After 20 min, the network attained a highly regular 
pattern, with synchronized bursts of similar spike form and time course. These 
observations were completely consistent with the classification of the unknown 
compound as an antagonist of inhibitory transmission with strong similarity to other 
compounds capable of inducing convulsant activity, such as the GABAA receptor 
inhibitor bicuculline.  Subsequent experiments were performed to explore the utility of 
network parameters and coefficients of variation as metrics for neuronal network 
performance using both TMPP and bicuculline.  In addition, we determined changes in 
network behavior resulting from TMPP exposure after pharmacological modulation of 
neurotransmitter pathways, including cholinergic and GABAergic types A and B. 

































  The restructuring of network spike patterns by TMPP is demonstrated in Fig. 2.4.  
The evolution of activity in terms of the variables burst rate and spike rate (per min) is 
shown for a 150 min time period (Fig. 2.4A).  The network responded to 20 µM TMPP 
with a small increase in spike production (25 ± 1.9%, mean ± SEM, n=41 units), but with 
a very large increase in burst production; the burst rate significantly rose from a control 
level of 3 ± 1.1 bpm (n=14 channels) to 30 ± 0.8 bpm after exposure to TMPP.  No 
further statistically significant changes were observed in either spike or burst rate with 
subsequent increases of the TMPP concentrations to 40 and 80 µM, suggesting that 
receptor saturation is reached near 20 µM.  As shown in the raster display (Fig. 2.4B), the 
native activity consists of spontaneous spiking with minimal coordinated bursting.  In this 
network, TMPP generated network bursting that is coordinated among channels, without 
causing a major change in spike production (Fig. 2.4C).   
Figure 2.3  Burst pattern changes in response to TMPP shown with integrated spike 
data as displayed on a chart recorder.  (A) Native activity showing bursts of short 
and long durations, with irregular burst amplitudes.  (B) The same channels 20 min 
after application of 2 µM TMPP.  Burst durations have regularized with the 
disappearance of long duration bursts (arrows), and burst amplitudes have increased 
on most channels (especially Ch 2 and 7). (C & D) Responses of a different network 
to 100 µM TMPP applied at the arrow.  Within 3 minutes, the activity transitions 
from irregular, partially coordinated bursting to a much more regular and 
synchronized pattern.  (D) 20 min after TMPP application, the network has reached 
a quasi-periodic oscillatory state.  Each bar represents 1 min. Arrows indicate time 
of TMPP addition. Amplitude of traces is proportional to spike frequencies within 
bursts. 
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TMPP decreased the variability of network bursting, as summarized in Fig. 2.5, for 
burst duration, interburst interval (the interburst interval extends from the end of one 
burst to the beginning of the next burst), and burst rate.  The mean coefficients of 
variation (CVs) are plotted from 8 experiments (197 total channels) for both control and 
TMPP-treated conditions.  In each case, the CVs were markedly decreased in a 
statistically significant manner after exposure to TMPP.  Such increases in the reliability 
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Figure 2.4  (A) Temporal evolution of burst and spike rate of a frontal cortex culture 
subjected to three concentrations of TMPP.  The spike production per minute 
(circles) is minimally affected by the addition of 20 µM TMPP, but the burst rate 
increases from 2 to 30 bpm about 5 min after this addition.  Subsequent increases of 
TMPP to 40 and 80 µM produce no further increases.  (B) Spike raster display of 
activity at the 25 min mark in A.  Note the lack of bursting and activity coordination 
among the 20 channels depicted.  (C) The same channels at the 45 min mark in A.  
Burst organization and channel coordination can be seen.  Both panels represent 5 
sec of data.   
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frequencies within each burst, are characteristic of compounds with known epileptogenic 
properties. 











































Figure 2.5  Mean coefficients of variation for burst duration, interburst interval, and 
burst rate during spontaneous activity (clear bars) and in the presence of TMPP (20-
100µM, solid bars) calculated for 8 separate cultures (197 channels).  20 min 
segments of activity for each experimental condition (episode) in individual 
experiments were used to calculate mean and standard deviations of each burst 
variable for individual channels.  Episode CVs for each channel were calculated, and 
a mean network CV was obtained from all channel CVs.  TMPP decreases the 
temporal variability of these burst variables.  Error bars represent SEM.  All changes 
are statistically significant (ANOVA, p<0.05). 
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  Although pattern changes to TMPP influences can be determined unmistakably by 
visual inspection (cf Fig. 2.4), a simple relationship between burst rates and TMPP 
concentration does not exist because of a dependence on the native activity of the test 
culture.  As shown in Fig. 2.6, burst rates increased when initial burst activity was 
relatively low but decreased when the native activity was high.  Healthy cultures often 
can exhibit a wide range of native bursting activity and can yield mean activity values not 
unlike data depicted in Figs. 2.6A and 2.6B.  Data from two experiments (Fig. 2.6C), in 
which the difference between TMPP and native activity is plotted against the native 
activity, show an approximately linear relationship with a crossing of the zero line at 16 
bpm.  These data imply that cultures with native burst rates near 16 bpm will show little 
change in burst rate with application of TMPP.  However, other variables, such as burst 
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Figure 2.6  Dependence of TMPP burst rates on native activity states.  (A, B) Single 
channel profiles of burst rate changes upon addition of TMPP.  High native burst 
rates are reduced by TMPP, whereas low initial rates are increased.  Panel C shows 
data from two networks (27 channels total) plotted as the difference between TMPP 
and native burst rates against the native burst rate.  The crossover occurs at 
approximately 16 bpm. 
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Comparison with Bicuculline 
 
 The pattern changes induced by TMPP were very similar to what is seen after 
application of bicuculline methiodide.  Despite the dramatic effect on bursting, network 
synchronization, and variability of burst parameters shown by both compounds, neither 
compound exerted a consistent effect on spike shape or spike amplitude (Fig. 2.7). Fig. 
2.8A shows such a bicuculline response on three channels from a slow speed chart 
recording.  Increases in burst amplitude and cross-channel synchronization comparable to 
those changes evoked by administration of TMPP (Fig. 2.3) were observed. Like TMPP, 






































Figure 2.7 Effects of bicuculline and TMPP on waveform shapes. Each line 
represents the mean of 50 consecutive action potentials. There are no consistent 












































































































































Figure 2.8  Network responses to 40µM bicuculline added at arrow.  (A) Integrated 
burst data from a slow speed chart recording showing a transition from native 
bursting to a disinhibited activity state characterized by increases of spike 
frequencies within burst (increased integrated burst amplitudes), regularization of 
burst amplitudes, and activity coordination among channels.  (B) The burst rates 
established under bicuculline are a function of the initial activity.  Low initial BR are 
increased, whereas high initial BR are decreased.  The crossover occurs at 
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Fig. 2.9A illustrates network responses to co-application of bicuculline and 
carbachol, a drug combination used to elicit hippocampal theta oscillations in vitro 
(Lukatch and MacIver, 1997; Psarropoulos and Dallaire, 1998; Williams and Kauer, 
1997).  As expected, immediate increases in both burst and spike rates were produced 
after the administration of carbachol (30 µM).  After washout, the network activity 
recovered to a stationary state.  The experiment then was repeated with TMPP substituted 
Figure 2.9 (A) Evolution of activity under 50µM bicuculline and 50µM TMPP 
showing similar burst and spike rates.  Subsequent additions of 30µM carbachol also 
produced almost identical effects.  (B and C) Burst interval distributions for the 
conditions shown in A also reveal a highly similar shift to shorter intervals with 
distribution modes at approximately 1 sec. 
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for bicuculline.  The similar response profiles of bursting and spiking to both 
combination of compounds suggest that TMPP and bicuculline share common 
mechanisms.  Figs. 2.9B and 2.9C shows histograms of interburst intervals constructed 
from the data shown in Fig. 2.9A. The distribution under 50 µM TMPP is narrower than 
that under 50µM bicuculline, reflecting a more stable oscillation during the TMPP 
episode. Nevertheless, bicuculline/carbachol and TMPP/carbachol produced nearly 
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A Figure 2.10  Bath application of 
GABA inhibits spiking in a 
dose dependent, reversible 
fashion.  (A) Responses of a 
sample of 4 out of 24 channels 
as GABA was titrated from 1-
10 µM, followed by two 
complete medium changes, 
which restored spiking to near 
initial levels of activity.  (B) 
Mean spike rate graph 
constructed from 24 separate 
channels from the experiment 
shown in A.  Vertical lines mark 
the times when GABA 
concentrations were raised to 
the concentration indicated.   
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Mechanism of Action of TMPP 
 
To test the hypothesis that TMPP and bicuculline share a common mechanism of 
action, we examined the competitive interactions of GABA and TMPP.  All neuronal 
tissues in culture responded to GABA.  Spinal monolayer cultures were shown to 
terminate bursting at 18 ± 5.0 µM (mean ± SD, n = 12 cultures, Jordan, 1995).  Frontal 
cortex tissue may be more sensitive and terminates bursting and spiking between 10 and 
15 µM.  Spike rate responses of 24 discriminated units from a frontal cortex culture were 
acquired (Fig. 2.10A), and a mean spike rate of all identified units as a function of time 
and GABA concentration was derived (Fig. 2.10B).  Bath application of GABA inhibited 
spontaneous activity in a reversible, concentration-dependent manner.  All spiking was 



























































Dose response curves were calculated from the mean spike rate graphs generated 
by each network (Fig. 2.11).  The EC50 for inhibition of spontaneous spike rate by GABA 
was 2.8 µM (2 cultures, n=48 channels).  Repeating the experiment in the presence of 
20µM TMPP (2 cultures, n= 56 channels) shifted the dose-response curve to the right, 
with an EC50 of 7.0 µM.  A further increase in TMPP concentration to 200 µM (1 culture, 
n=20) resulted in an EC50 for GABA inhibition of 20.5µM.  The similar shapes of the 
dose-response curves, with nearly parallel center segments of the curves, and the 
maintained GABA efficacy in the presence of 20 or 200µM TMPP implies competitive 
antagonism by TMPP.   
 
Kao et al. (1999) reported that 5µM TMPP decreased both amplitude and 
frequency of spontaneous inhibitory postsynaptic currents (sIPSCs).  The decrease in 
amplitude was consistent with an antagonistic effect at the GABAA receptor.  The 
mechanism underlying the decrease in sIPSC frequency, which implies a presynaptic 
locus, is unexplained.  A possible explanation could be action at the GABAB receptor, 
which has been shown to decrease release of both glutamate and GABA (Capogna et al., 
Figure 2.11  TMPP is a competitive antagonist of GABA inhibition of spiking 
activity. (A) Dose response curves for GABA inhibition of spontaneous spiking 
under three conditions, GABA only, in the presence of 20 µM TMPP, and in the 
presence of 200 µM TMPP.  EC50s were 2.8, 7.0 and 20.5 µM, respectively.  (B) 
GABA titration repeated with the competitive GABA receptor antagonist 
SCH50911 (50 µM), limiting effects to those mediated by the GABAA receptor, 
resulted in an EC50 of 4.0 µM.  With both 50 µM SCH50911 and 20 µM TMPP, the 
curve was shifted to the right, with an EC50 of 10.0 µM.  The effects of the two 
antagonists are additive, possibly indicating separate sites of action.  
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1996; Poncer et al., 2000; Stevens et al., 1999).  To test the possible interaction of TMPP 
with the GABAB receptor, we first titrated GABA in the presence of the competitive 
GABAB antagonist, SCH50911 (Fig. 2.11B).  With the GABAB receptors blocked, 
GABA inhibited spiking with an EC50 of 4.0 µM (n=12), which is significantly different 
from the EC50 of 2.8 µM for GABA action through both GABAA and GABAB receptors 
(Fig. 10, p<0.05).  This indicates a contribution of GABAB receptors to the inhibition of 
spontaneous spiking by bath applied GABA.  However, when GABA was titrated in the 
presence of SCH50911 (50 µM) and 20 µM TMPP, an EC50 of 10.0 µM (n=12 channels) 
was obtained.  The inhibition of spiking, with both GABA receptors blocked, was 
significantly different from GABA inhibition in the presence of only TMPP.  This result 
shows that the effects of TMPP and SCH50911 are additive in antagonizing GABA 















The present study has demonstrated the utility of neuronal networks for detection 
and classification of a model neurotoxicant, TMPP. TMPP-induced changes in network 
properties were evident within minutes of administration, such that TMPP could be 
quickly classified as a convulsant.  Detailed analysis of spike and burst parameters, in 
particular the CVs, revealed that TMPP has a profile similar to network disinhibitors, 
such as bicuculline, a well-known antagonist of the GABA receptor.  These findings are 
consistent with TMPP studies that span from whole animal neurobehavioral and EEG 
measurements (Lin et al., 1998; Lindsey et al., 1998) to studies at the molecular level 
focusing on GABAA receptor function (Higgins and Gardier, 1990; Kao et al., 1999). 
 
Previous studies have shown that the effects of TMPP are rapid and do not depend 
on a metabolite of the compound (Rossi et al., 1998).   Binding assays have revealed that 
TMPP binds to the GABA-benzodiazepine receptor complex with greater affinity than 
does picrotoxin (Bowery et al., 1976; Casida et al., 1976; Higgins and Gardier, 1990), but 
with no apparent binding affinity for GABAB, noradrenergic, dopaminergic, or 
cholinergic receptors (Jung et al., 1995).  Past work examining ion flux (Higgins and 
Gardier, 1990), receptor binding (Bowery et al., 1976; Casida et al., 1976; Toia and 
Casida, 1987), and membrane currents (Kao et al., 1999) have demonstrated that GABAA 
receptor function in dissociated neural cells can be affected by TMPP.  The results 
presented here confirm these findings: Competitive inhibition of GABA and a lack of 
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influence on the GABAB receptor were demonstrated by the dose response curves of Fig. 
2.11.   
  
 TMPP is not an "excitatory" substance as is glutamate, NMDA, or even ACh.  
Rather, its responses are classically "disinhibitory".  Whereas excitation increases spike 
production without generating organized patterns, disinhibition causes highly regular, 
synchronized burst patterns.  Although an increase in spike production often is associated 
with this change, it is not the salient feature.  TMPP fits unmistakably in the category of 
the disinhibitory agents studied so far, and its actions closely resemble the effects of 
bicuculline.   
 
 The results presented also demonstrate that the monitoring of a single activity 
variable is not sufficient for reliable detection of convulsion-inducing compounds.  This 
is seen in Fig. 4, in which application of 20-80 µM TMPP elicited only minor changes in 
spike rates, but produced a dramatic reorganization of the network activity into 
synchronous, quasi-periodic burst episodes.  Burst rate changes also have a “blind spot”.  
This phenomenon also is evident in Figs. 6 and 7, which demonstrate that the burst rates 
resulting from disinhibition with either TMPP or bicuculline depend upon the native burst 
rates of the network.  Networks with spontaneous native activity ranging from 14 –18 
bpm may not show the presence of a burst-inducing compound, if only this one variable 
is observed.  However, burst durations, spike frequencies within bursts, coordination 
among channels, and, especially, the regularity of all activity variables change noticeably 
upon addition of TMPP.   
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 The native burst rate at which a disinhibitory compound elicits only minor burst rate 
changes (near the cross-over points of Figs. 6 and 7) may be tissue- or compound- 
specific.  Although the mechanism is not clearly understood, it probably is linked to burst 
after-hyperpolarization.  As TMPP and bicuculline increase spike frequencies in bursts, 
the burst duration variability is lessened, and the burst duration generally increases.  
Small, short-duration bursts are eliminated from the pattern.  Consequently, for a network 
bursting above 20 bpm, application of a disinhibitor causes a reduction in burst rate. 
Networks with slow initial activity have large interburst intervals that can accommodate 
increases in burst rates and durations, without encountering AHP limiting effects.  These 
examples highlight the need for a multivariate analysis approach to provide reliable 
quantification of compound responses.   
 
 It is important to emphasize that the concentrations at which networks respond 
correlate with those used in vivo.  This was shown for trimethyltin chloride (Gramowski 
et al., 2000) and for the cannabinoid mimetic anandamide (Morefield et al., 2000).  With 
regard to the relevance of the concentrations used in the present study, it has been 
demonstrated that IP injection of TMPP into adult Sprague-Dawley rats causes partial 
kindling of electroencephalographic paroxysms at ≥0.1 mg/kg, subclinical seizures at 
≥0.2 mg/kg, clinical seizures at ≥0.4 mg/kg, status epilepticus at ≥0.6 mg/kg, and death at 
>0.7 mg/kg (Psarropoulou and Dallaire,1998).  It recently has been shown that a single IP 
injection of 0.075 mg of TMPP induces a peak blood concentration of 1.5 µg/ml (Rossi et 
al., 1998).  If we assume a rat of average mass (250 g) blood volume (64 ml/kg), then 0.3 
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mg/kg corresponds to approximately 1 µM TMPP.  This crude approximation, which 
assumes no binding to blood proteins, suggests that the concentrations used in vitro are 
consistent with the TMPP dosage range associated with neurobehavioral alterations. 
 
 Neurons, by virtue of intrinsic, electrophysiological mechanisms, represent efficient 
transducers that report dynamics of cell death, receptor-ligand interactions, alterations in 
metabolism, and generic membrane perforation processes.  However, single neurons are 
vulnerable and unreliable, and only networks of neurons form robust, fault-tolerant, 
spontaneously active dynamic systems with high sensitivity to their chemical 
environment and reproducible reactions (Gross et al, 1997, Morefield at al., 2000).  
Networks in culture generate response profiles that are concentration and substance-
specific and react to a broad range of compounds (Gross and Kowalski, 1991; Gross et 
al., 1992; Gross, 1994; Rhoades and Gross, 1994; Gross et al., 1997).  Additionally, 
changes in action potential patterns and action potential shape often can be detected 
before irreversible cell damage occurs.  These reversible changes provide rapid warning 
and the opportunity for cycling varying concentrations of toxins through the same 
network.   
 
 
 Before in vitro systems can be used effectively, reliable data must be established on 
intra- and interculture repeatability, response sensitivity, and substance-specific response 
patterns.  These include highly reproducible generation of test cultures, optimization of 
substance application protocols, and development of data analysis procedures that can 
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provide key data in real time.  Thereafter, a new, powerful test system should emerge 
with the potential of making substantial contributions to the rapid screening of new 
compounds and the establishment of concentrations limits at which reversible and 
irreversible toxic effects commence.  In light of the demonstrated longevity of neurons in 
culture (6-9 months, Gross, 1994; Kamioka et al., 1996), such test systems also will allow 
chronic exposure studies and investigations of developmental influences.  Preliminary 
data suggests this concept is viable and that responses will be obtained from all 

















Additional Considerations for the Use of Neuronal Networks 




This work demonstrates the utility of neuronal networks as detectors of 
compounds possessing neural activity. It is likely that neuronal networks are capable of 
reporting the presence of most neurally active compounds that: a) bind to receptors, b) 
bind to or are solublized in the neuronal membrane, c) can be internalized, with 
subsequent effects on intracellular processes, including gene expression or metabolic 
processes; d) alter the function of ion channels, or e) change the intrinsic excitability of 
the neurons. The concentrations at which the networks react are usually within the ranges 
shown to produce physiological changes in whole animals. Thus, the promise of neuronal 
networks as biosensors is supported by a rapidly growing body of data. If this promise is 
realized, neuronal networks could fill a void that exists in current methodologies for 
human risk assessment in areas contaminated with pollutants, pathogens, or other agents. 
This is evidenced by a general inability to: a) simultaneously detect large numbers of 
possible threats, especially unknown or unanticipated ones, b) characterize the 
functionality of known agents that have been identified using conventional techniques, 
and c) predict human performance decrements caused by low levels of agents or 
synergistic effects of environmental toxicants. 
 
This work also demonstrates how a novel compound, once detected, can be 
classified according to its action in changing the activity of the networks. The effects of 
TMPP on organization of activity into bursts and in increasing the frequency of spikes 
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within those bursts were comparable to those seen with bicuculline, and allowed the 
classification of TMPP as a disinhibitory substance. By accumulating a database of 
model compounds that produce different effects on neuronal network behavior, it is 
hoped these effects can be separated into distinct categories. One simple classification 
scheme might have three categories: Excitatory, Inhibitory, and Disinhibitory. Examples 
of compounds that might be considered representative of each category are respectively: 
a) glutamate, b) GABA, and c) bicuculline.  All of these produce reliable network 
responses at narrow concentration ranges, which is a prerequisite for the use of a 
potential compound in the construction of a response template. Comparison of responses 
elicited by novel compounds with these templates will allow this novel compound to be 
categorized. 
 
Conventional methods for detecting environmental threats are based primarily on 
chemical, antibody- or nucleic acid-based assays, which rely on chemical properties or 
molecular recognition to identify a particular agent. These methods can precisely identify 
compounds for which they are specifically tailored, but cannot detect compounds lacking 
that known molecular signature expected by the detector. Neuronal networks, on the 
other hand, respond to such a wide variety of substances that the identification of an 
unknown compound is problematical. The difficulty is exacerbated by the fact that rarely, 
if ever, will the absolute concentration of the compound be known. It may be feasible to 
construct floating dose-response curves, in which the concentration of the unknown can 
be varied relative to the concentration that first elicited an effect, but this methodology 
has not been proven. It is possible that an expert-based system, with a large library of 
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neuronal-network response profiles and utilizing algorithms similar to those used by 
speech-recognition software, could be developed to enable unknown identification. 
 
If the goal of using neuronal networks as biosensors in civilian areas such as 
water monitoring or in military applications for real-time warning of chemical or 
biological attacks is to be attained, advancements in current laboratory-based technology 
must be made. 
 
Needed advancements include:  
• Implementation of large-scale production of cultures with reproducible responses 
to a wide range of neuroactive substances,  
• Production of a system to maintain a stable artificial environment, with automated 
measurements of temperature, pH, osmolarity, glucose, amino acids, 
neurotransmitters, etc. from microliter-size volumes on a continual basis, to 
ensure that changes in network activity reflect modulation by potential threats and 
not variations in the network environment 
• Development of a methodology to validate data generated from the cultures, so 
that false-positives can be minimized, as well as a method to interrogate the 
network, and ensure that it remains functionally responsive, 
• Design of a system for automatic determination of the meaning data gathered, so 
that an alarm can be generated appropriate for the detected threat, and 
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• Determination of the set of network activity variables providing the most robust 
visualization of activity changes elicited by environmental threats, enabling 
compounds to be "fingerprinted" according to the changes they produce. 
 
Each of these advancements presents unique challenges. The realization of all of them 
will require an interdisciplinary effort combining tissue-culture, computer science, 
statistics, fluid mechanics, physical chemistry, and neuroscience. The goal of 
implementing neuronal cultures as biosensors always must be driven by the cultures 
themselves, however. Without healthy, spontaneously active networks, all other efforts 






























NMDA RECEPTOR DEPENDENT PERIODIC OSCILLATIONS IN 
CULTURED SPINAL CORD NETWORKS 
Summary 
 
Cultured spinal cord networks grown on microelectrode arrays display complex 
patterns of spontaneous burst and spike activity. During disinhibition with bicuculline 
and strychnine, synchronized burst patterns emerge routinely. However, the variability of 
both intra- and interculture burst periods and durations are typically large under these 
conditions. As a further step in simplification of synaptic interactions, we blocked 
excitatory AMPA synapses with NBQX, resulting in network activity mediated through 
the NMDA receptor (NMDAONLY). This activity was abolished by APV, an NMDA 
receptor antagonist. The oscillation under NMDAONLY conditions at 37 
0C was 
characterized by a period of 2.9 ± 0.3 s (16 separate cultures). Over 98% of all neurons 
recorded participated in this highly rhythmic activity. The temporal coefficients of 
variation, reflecting the rhythmic nature of the oscillation, were 3.7, 4.7, and 4.9 % for 
burst rate, burst duration, and inter-burst interval, respectively (mean CVs for 16 
cultures). The oscillation persisted for at least 12 hrs without change (maximum 
observation time). Once established, it was not perturbed by agents that block mGlu 
receptors, GABAB receptors, cholinergic receptors, purinergic receptors, tachykinin 
receptors, 5-HT receptors, dopamine receptors, electrical synapses, burst 
afterhyperpolarization, NMDA receptor desensitization, or the hyperpolarization-
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activated current. However, the oscillation was destroyed by bath application of NMDA 
(20-50µM). These results suggest a presynaptic mechanism underlying this periodic 
rhythm that is solely dependent upon the NMDA synapse. When the AMPA/kainate 
synapse was the sole driving force (n=6), the resulting burst patterns showed much higher 
variability and did not develop the highly periodic, synchronized nature of the 
NMDAONLY activity. Network size or age did not appear to influence the reliability of 
expression of the NMDAONLY activity pattern. For this reason, we suggest that the 
NMDAONLY condition unmasks a fundamental rhythmogenic mechanism of possible 
functional importance during periods of NMDA receptor dominated activity, such as 

















The mechanisms driving the spontaneous activity of neuronal ensembles and their 
generation of spatio-temporal spike and burst patterns are difficult to study quantitatively 
in vivo because simultaneous monitoring of neurons in small ensembles is technically 
extremely difficult.  However, neuronal networks grown in culture provide simpler 
systems in which a quasi-monolayer architecture can be coupled to planar microelectrode 
arrays that allow ensemble recording over long periods of time.  We used murine spinal 
cord networks growing on such microelectrode arrays (Droge et al., 1986; Gross, 1994) 
to obtain long-term, multisite recording of spontaneous and pharmacologically modified 
activity (Fig.1.1).  The chemical environment can be controlled with precision and 
specific activity states can be maintained and investigated for many hours, a time period 
usually not achievable in vivo.  Although this provides a unique opportunity to investigate 
basic cellular and ensemble mechanisms related to the observed activity states, networks 
in culture still represent the interactions of multiple synaptic driving forces, resulting in 
complex spike and burst patterns. 
 
In mammalian development, there is a short period during which neuronal 
networks are connected by purely excitatory synapses (Habets et al., 1987; Jackson et al., 
1982). Throughout this developmental window, or when inhibitory synapses are blocked 
in more mature tissue, networks exhibit bursts of action potentials that are roughly 
synchronized across the population. It is suggested these synchronous population bursts 
are important in pruning and sculpting neuronal circuits during development (Tosney and 
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Landmesser, 1985). However, the mechanisms that initiate and terminate such bursting 
are unclear, especially in the absence of inhibitory circuitry. 
 
Disinhibition of cultured networks, organotypic spinal cord cultures, and acute 
spinal cord preparations with inhibitory neurotransmitter antagonists reliably induces 
oscillatory behavior consisting of bursts of action potentials concomitant with 
intracellular Ca+2 oscillations  (Lawrie et al., 1993; Rhoades and Gross,1994; Robinson et 
al., 1993; Wallen and Grillner, 1987; Wang and Gruenstein, 1997).  Similar results also 
have been obtained by increasing excitability with ionic manipulations, such as low Mg+2 
or increased extracellular K+. Fictive locomotion can be elicited in intact spinal cord 
preparations, with burst patterns alternating between the right and left sides of the cord, 
by application of 5-HT, NMDA, or 5-HT and NMDA in combination or by elevated 
extracellular K+ (Bracci et al., 1998; MacLean et al., 1998; Wallen and Grillner, 1987). 
These studies have shown that inhibitory conductances are not essential for 
rhythmogenesis, but the relative contributions of cellular versus network properties in the 
production of rhythmic motor output are unresolved. 
 
In order to study burst patterns in excitatory-only coupled networks, we 
pharmacologically reduced the inhibitory and excitatory neurotransmitter systems that 
drive spontaneous activity in cultured murine spinal cord networks to one dominated by 
NMDA receptor activation, a situation reminiscent of that found during the 
embryonic/early postnatal period (Scheetz and Constantine-Paton, 1994).  The resulting 
activity (termed "NMDAONLY") is characterized by (1) a highly regular burst oscillation, 
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as evidenced by the low CV values for population burst variables, (2) burst 
synchronization among units in the network, and (3) a stationary burst rate of 21.0 ± 2.0 
bpm  (mean ± SD, n = 16 cultures), which is independent of the initial activity state. 
Blocking NMDA receptors in the presence of bicuculline (BCC) and strychnine (STR), 
which left the AMPA/kainate glutamate receptor subtypes as the sole driving force (n=6), 
produced network oscillations at a much lower level of organization as that seen during 
NMDAONLY activity.. It appears that the NMDA receptor may be uniquely suited for 
production of the highly stable and uniform burst oscillations.  
 
We explored burst termination mechanisms with potential contribution to 
NMDAONLY activity. These include afterhyperpolarization (AHP), receptor 
desensitization, and depression of neurotransmitter release (O'Donovan, 1999). Blocking 
both AHP and NMDA receptor desensitization did not affect established NMDAONLY 
oscillations. Synaptic depression, possibly resulting from exhaustion of the readily 
releasable pool (RRP) of excitatory neurotransmitter vesicles, has been observed in 
disinhibited whole spinal cord and spinal cord slices (Bracci et al., 1996a; Streit, 1993). 
CA3 population activity can be dominated by vesicle depletion and the time required to 
refill the RRP (Staley et al., 1998). Our results suggest that strong synaptic depression 
caused by the depletion of the RRP could serve as burst termination mechanism during 







Cell culture procedures were identical to those described in Chapter 2 for spinal 
cord cultures. 
 
Drugs and Solutions 
Apamin, atropine, bicuculline, CaCl2, charybdotoxin, curare, Evan's blue, glycine, 
KCl, MgCl2, norepinephrine, and strychnine were purchased from Sigma Chemical Co., 
St. Louis, MO. APV, haloperidol, L-733,060, MCPG, NBQX, and SCH 50911 were 
purchased from Tocris Cookson, Ballwin, MD. Carbenoxolone was purchased from ICN, 
Costa Mesa, CA. Methysergide maleate was obtained from RBI, Natick, MA. 
 
Extracellular Recording Procedures and Data Analysis 
MEAs were placed into constant-bath recording chambers (Gross and Schwalm, 
1994; Gross, 1994) and maintained at 37°C on a microscope stage.  The pH was 
maintained at 7.4 with a continuous stream of filtered, humidified, 10% C02.  Stainless 
steel chamber components were sterilized via autoclaving before each experiment.  
Neuronal activity was recorded with a two-stage, 64-channel amplifier system (Plexon 
Inc., Dallas), and digitized simultaneously via a Dell 410 workstation (spike analysis) and 
a Masscomp 5700 computer (burst analysis). Total system gain used was normally 12K. 
Spike identification and separation were accomplished with a template-matching 
algorithm (Plexon Inc.) in real time to provide single unit spike rate data. In addition, 
whole channel (multiple-units/ channel) data were analyzed offline using custom 
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programs for burst recognition and analysis. Burst patterns derived from spike integration 
(τ = 200ms) provided a high signal-to-noise feature extraction that has been shown to 
reveal modes of neuronal network behavior (Gross et al., 1994).  From this approach, 




Statistical significance was determined using two sample Student's t-test with 
P<0.05 considered as significant.  In order to quantify the periodicity of the bursting, as 
well as the synchronization of the neuronal population participating in each burst event, 
we calculated the coefficient of variation (CV) across time and across the network after 
15-30 min stabilization periods to allow the networks to reach a steady activity state after 
pharmacological manipulation. Figure 3.1 summarizes the calculation of CVs.  CVtime 
reflects the periodic character of the activity pattern (Bracci et al., 1996a). CVnetwork 
reflects the synchronization between different neurons.  CVtime was obtained from minute 
means of each channel by averaging over the experimental episode. The episode CVs per 
channel then were averaged to yield temporal network means. CVnetwork was obtained by 
averaging values in 60-sec bins, followed another average across channels that yielded a 
CVnetwork for each minute. These CVs were averaged for each experimental episode. The 
CVs were calculated for different burst variables: burst rate (BR), burst duration (BD), 
and interburst interval (IBI) during different experimental episodes (spontaneous, partial 
disinhibition with bicuculline, and NMDAONLY). Large CVs imply a wide range of 
variability in the activity of the networks across both time and the neurons recorded. 
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Hence, if a population was synchronized, but fluctuated together, low CVnetwork and high 
CVtime were obtained. Conversely, a non-synchronized network with several regular 
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Figure 3.1 Determination of temporal regularity and network synchronization using 
coefficients of variation (CV).  All calculations are based on one minute bins during 
which a specific burst parameter (bp) either is logged as a number for burst rate or 
averaged for burst duration and inter-burst interval.  These values are used to obtain 
episode means with CVs for experimental episodes (left/right), or minute means for 
each minute of the experimental episode (top to bottom).  The episode CVs (CVtime) 
for each channel represent a measure of temporal pattern fluctuation for that 
channel.  Averaged across the network, CVtime reflect pattern regularity even if 
several patterns exist and even if they are not synchronized.  Conversely, the CVs 
obtained by averaging minute values across channels (CVnetwork) represent channel 
coordination.  Averaged across the experimental episode, CVnetwork reflect the degree 
of network synchronization, even if the pattern fluctuates in time.   
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Results 
In their original medium (native state), spinal cord networks typically exhibited 
multiple patterns of activity (Fig 3.2a). Disinhibition with the GABAA receptor 
antagonist BCC (40µM) elicited robust bursting activity that was synchronized across the 
network (Fig 3.2b). However, under BCC, the temporal variation in the burst period still 
was high. Further disinhibition by the blocking of glycine receptors using 1 µM STR did 
not reduce the variability of the burst period. When AMPA/kainate receptors were 
subsequently blocked with 10 µM NBQX, the networks were entrained to one common, 
highly periodic burst pattern activity (Fig 3.2c). This unique activity state persisted for up 
to 12 hrs without change in regularity (Fig. 3.2d). 
 
Data presented in this report were obtained from 16 separate cultures. In a subset 
of 8 experiments, the oscillations with a period of 2.8 ± 0.2 s (mean ± SD), began almost 
immediately after the addition of NBQX, which followed the sequential addition of BCC 
and STR. This oscillation period was associated with high spatial and temporal burst 
pattern regularity. The eight remaining networks established longer burst periods after 
NBQX addition (4.3- 3.8 s) with less regularity of the bursts, suggesting that additional 
inhibitory mechanisms, such as GABA receptor inhibition of vesicle release (Isaacson 
and Hille, 1997), might have prevented the establishment of the unique 2.8 s oscillation. 
Indeed, the addition of 50 µM SCH 50911 (a soluble GABAB antagonist) decreased the 
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Figure 3.2  A, B, C: Simultaneous spike trains from 15 discriminated neurons 
during different experimental episodes (25 s samples). A: Spontaneous native 
activity displaying tonic and phasic firing with occasional coordinated bursting. B: 
40µM bicuculline transforms the activity into a bursting pattern that is coordinated 
across neurons but with a high degree of variability in the interburst intervals (IBI) 
and burst durations (BD). C: NMDAONLY activity consists of a synchronized 
periodic burst pattern. Two coefficients of variation CVtime and CVnetwork are 
obtained from the temporal sequence (horizontal arrows) and the channel sequence 
(vertical arrows), respectively. CVtime provides a measure of the temporal variation 
of a specific network activity variable (e.g. BR, BD, IBI). CVnetwork reflects the 
degree to which activity is coordinated among recorded neurons within the network. 
D: The long-term stability of the NMDAONLY burst oscillation is demonstrated with 
chart recorder trace of integrated activity (τ = 0.7s) from a single channel at 5 min 
and after 12 hours of continuous NBQX exposure. 
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In the three remaining networks, the sequential application of 40 µM 
norepinephrine (NE), in addition to the above four compounds, led promptly to the 
adjustment of the burst oscillation to a regular, periodic burst period of 2.8 ± 0.2 sec 
(mean ± SD). NE is known to affect NMDA receptor desensitization and the slow burst 
afterhyperpolarization, two other potentially inhibitory mechanisms (Legendre et al., 
1993; Madison and Nicoll, 1986; Tong and Jahr, 1994; Tong et al., 1995). It is important 
to emphasize that SCH 50911 and/or NE had no effect if they were added after the 
NMDAONLY oscillation was established. These results indicate that GABAB receptor 
mediated inhibition of neurotransmitter release, or mechanisms sensitive to NE were 
sometimes sufficient to prevent the characteristic NMDAONLY pattern from developing 
but were not necessary for its maintenance. It is also important to note that the low CVs 
characterizing the NMDAONLY activity pattern were not obtained if the network burst rate 
following BCC/STR/NBQX was lower than 17 bpm. High pattern regularity and the 
characteristic 2.8s oscillation period were always linked. 
 
The mean periods with associated SDs of all three pharmacological manipulations 
(1) BCC/ STR/ NBQX, (2) BCC/STR/NBQX/SCH, and (3)BCC/STR/NBQX/SCH/NE 
were not significantly different (p>0.05, t-test for two samples), and thus data from all 16 
experiments were pooled for subsequent analysis. In order to quantify the periodicity of 
the bursting, as well as the synchronization of the neuronal population participating in 
each burst event, we calculated the coefficients of variation for several burst variables 
across time and across the network. All calculations were done with binned data from 1 
min time intervals. The results of the CV calculations for three different burst variables 
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(burst rate (BR), burst duration (BD) and interburst interval (IBI)) under three different 
conditions, (spontaneous, disinhibited with 40 µM bicuculline, and under NMDAONLY) 
are summarized in Figure 3.3.  During native conditions, the CVs are large, implying a 
wide range of variability in the activity of the networks across time and between the 
neurons recorded.  40 µM bicuculline reliably reduced the CVs of all three burst 
parameters, showing that disinhibition has a stabilizing effect on network oscillations.  
However, reducing the synaptic driving forces to one mediated through the NMDA 
receptor only produced CVtime of 2.6-5% (Fig. 3.3a) and entrained virtually all recorded 
neurons (n=678, 16 experiments), as evidenced by the global CVnetwork for burst rate of 
2.8%. The dependency of the oscillation on the NMDA receptor was demonstrated with 
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In a series of six experiments, we applied BCC, STR, and 100 µM APV to 
examine whether AMPA receptors were able to produce the precise oscillation. In three 
of those six experiments, we also applied SCH50911 and NE. In no case did the resulting 
activity approach the precision of the NMDAONLY condition. For example, the mean 
CVtime for all six experiments was 13.5 (BR), 15.5(BD), and 22.4 % (IBI). While these 
values indicate a relatively stable oscillatory structure when the activity was driven solely 
by AMPA receptors, it did not match the degree of regularity and synchronization 
of the NMDAONLY activity (Fig. 3.4). These results indicate that NMDA receptor 





Figure 3.3 Mean coefficients of variation (16 experiments) for three experimental 
episodes: native, under 40µM bicuculline, and NMDAONLY (number of channels 
185, 185, 87 respectively). (A ) CVtime for three different burst variables: burst rate 
(BR), burst duration (BD), and interburst interval (IBI). CVtime reflects periodic 
behavior of the burst variable during a particular experimental episode. Large CVtime 
during the native episodes are due to the complex interaction of multiple 
neurotransmitter systems. (B) CVnetwork for the same three burst variables. CVnetwork 
reflects the inter-neuron synchronization across the network. When the GABAA 
antagonist bicuculline is applied, both CVnetwork and CVtime decrease for all variables 
to a range of 15-45%. When the activity is mediated solely by NMDA receptors, a 
further decrease in all CVs occurs (range 2.6-23%), with a concomitant reduction of 
the standard errors (error bars) obtained from global CVs of 16 different networks.  
All CVs in the two categories (time and network) are significantly different between 


















Figure 3.5 illustrates the evolution of activity with sequential addition of BCC, 
STR, and NBQX to the culture bath, culminating in the NMDAONLY activity pattern. The 
period of spontaneous activity shows low rates of bursting and spiking. Addition of 40 
µM BCC produces an increase in both activity variables within 5 minutes of application.  
However, the minute-to-minute variation in both variables still is quite large.  Addition of 
1 µM STR to remove the second set of inhibitory circuits elicits a further increase in 
burst and spike rates, accompanied by an increase in the temporal variability. The 
subsequent application of 10 µM NBQX results in a decrease in both burst and spike 
rates from the totally disinhibited activity.  Both measures stabilized at near constant 
levels after about 20 minutes. The thirty minutes following establishment of stable 
Figure 3.4 The highly periodic nature of the NMDAONLY activity (A) is not 
approached when synaptic interactions are limited to those mediated by AMPA 
receptors (B).  
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NMDAONLY activity had CVtime for BR, BD and IBI of 2.1, 4.1, and 2.9 % respectively.  
The dependence of the stationary activity on NMDA receptor mediated events is shown 
by the application of 100 µM APV at 412 min, which resulted in cessation of all bursting 
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Figure 3.5 Changes in spontaneous spike rate ( ) and burst rate () induced by 
sequential addition of 40µM bicuculline (BCC), 1µM strychnine (STR), 10µM NBQX, 
and 100µM APV. Each symbol represents the mean of 27 neurons (spike rate) and 14 
channels (burst rate). Vertical lines indicate times of drug application. Spontaneous 
activity increases within three minutes of bicuculline application at 170 minutes. 
Strychnine application at 270 minutes induces a further increase in both bursting and 
spiking accompanied by an increase in temporal variability. Blocking AMPA receptors 
with NBQX at 360 minutes reduces both bursting and spiking to levels intermediate to 
BCC and STR. Note the greatly reduced activity fluctuation within 20 min after NBQX 
application. APV abolishes all bursting and most spiking within 10 minutes of 
application, demonstrating the dependence of the activity on the NMDA receptor. 
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During NMDAONLY activity, spinal cord networks consistently oscillated within a 
very narrow range of burst rates. This activity was apparently independent of network age 
or neuronal density, as the 16 cultures from which the data was gathered ranged in age 
from 18-113 d.i.v. and were seeded at concentrations of 0.2-0.5 x106 cells/ml. Averaging 
burst rates from all 178 channels resulted in a mean global burst rate of 21.0 ± 2.0 bpm.  
 
For each channel, the NMDAONLY burst rate essentially was independent of the 
initial (native) burst rate. The distribution of burst rates for all 16 cultures (178 channels) 
under three different conditions is shown in Figure 3.6. Native activity prior to any 
pharmacological additions (Panel A),  ranged from 3 to 27 bpm. When BCC (40 µM) was 
added to block GABA mediated inhibition, the burst rate distribution was broadened, 
ranging from 3-36 bpm (Panel B). A peak in the distribution at 12-15 bpm indicates that 
the disinhibited network state has some preferential activity modes, but the typical BCC 
response varies between cultures. Panel C, which shows the NMDAONLY activity 
distributed from 18-24 bpm, demonstrates the reliability of expression of the oscillation 
in all cultures (n=16).  
 
Mechanisms Controlling Burst Oscillations 
Possible mechanisms that contribute to the unique characteristics of the 
NMDAONLY activity were explored using a battery of pharmacological agents 
summarized in Table 3.1. These agents may be divided roughly into (1) compounds that 
affect neurotransmitter release, (2) compounds that affect receptor desensitization, (3) 
 89 































3 6 9 12 15 18 21 24 27 30 33 36

























3 6 9 12 15 18 21 24 27 30 33 36

























3 6 9 12 15 18 21 24 27 30 33 36




















Figure 3.6 Burst rate 
distributions under 3 different 
conditions. A: Native activity 
of 16 cultures ranges from 3-
27 bpm. B: Disinhibition with 
40µM bicuculline results in a 
wider range (3-36 bpm), with 
a small peak at 12-15 bpm, 
indicating a preference for 
certain activity states, but with 
relatively low reliability of 
expression. C: NMDAONLY 
activity ranges from 18-24 
bpm. The narrow distribution 
shows the inter-culture 
reproducibility of the 
oscillation. Mean burst rates 
for 60 min intervals under 
each condition were 
calculated on a per-channel 

























TABLE 3.1: L ist of Pharmacological Agents Tested
Active Agent[µM]    Mode of Action    
Apamin [1]    Antagonist, small conductance 
(SK) Ca+2 activated K+ channels  
 
APV [5-100]    NMDA receptor antagonist 
 
Atropine [10-30]    Cholinergic muscarinic antagonist 
 
Bicuculline [40]    GABAA antagonist 
 
Ca+2 [1200-5000]    facilitation of neurotransmitter release 
 
Carbenoxolone [50-100]   Gap junction blocker 
 
Charybdotoxin [0.015] Antagonist, large conductance (BK) Ca+2 activated K+ 
channels 
 
Curare [10-20]    Cholinergic nicotinic antagonist 
 
Evan's Blue [50]    P2X receptor antagonist (adenosine) 
 
Glycine [10] Prevents glycine-dependent NMDA receptor desensitization 
(strychnine insensitive glycine site) 
 
Haloperidol [0.002]   Dopamine receptor antagonist 
 
K+ [5400-10000]    enhancer of neuronal excitability    
L-733,060 [0.002]   NK1 receptor antagonist (sub. P) 
 
MCPG [100-200]    Metabotropic glutamate receptor antagonist 
 
Methysergide [20]   Serotonin receptor antagonist 
 
Mg+2 [0-6000] inhibitor of neurotransmitter release, NMDA receptor blocker 
 
NBQX [10-20]    AMPA/kainate antagonist 
 
NMDA [50]    Selective agonist 
 
Norepinephrine [40-50] PKA activator (β-adrenergic receptor mediated), blocks burst 
after hyperpolarization, also counteracts Ca+2-dependent 
NMDA receptor desensitization  
 
SCH 50911 [50-100]   GABAB antagonist 
 
Strychnine [1]    Glycine receptor antagonist 
 
ZD7288 [50] Hyperpolarization activated cationic conductance blocker (Ih 
current) 
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Compounds affecting neurotransmitter release 
As previously described, when the main synaptic driving force had been reduced 
to NMDAONLY and network activity had stabilized to a highly periodic burst rate of 21.0 
± 2.0 bpm, the GABAB receptor antagonist SCH 50911 (50 µM) was without effect.  
However, in 8 experiments the combination of BCC/STR/NBQX resulted in a burst rate 
of less than 17 bpm. The variability in the burst parameters also was significantly higher 
than in the 8 experiments that responded with precise burst oscillations immediately after 
application of NBQX. In 5/8 of these cultures, SCH50911 increased the burst rate to 18-
24 bpm and established a highly periodic pattern of activity.  Thus, it appears that in our 
preparation, inhibition of neurotransmitter release through activation of GABAB receptors 
by endogenous GABA is sometimes sufficient to prevent the characteristic NMDAONLY 
pattern of activity from developing. These network specific effects may reflect 
fluctuations in network structure that are revealed by pharmacological manipulations.    
 
In three experiments, after NMDAONLY activity had been established, we titrated 
the Ca+2 concentration from 1.3 to 8.0 mM (Fig. 3.7). Ca+2 suppressed mean burst 
durations from 600ms at 3 mM Ca+2 to 300ms at 8 mM Ca+2 but did not affect the burst 
rate significantly. In two of these experiments, we subsequently raised K+ concentrations 
from the basal level of 5.4 mM to 8.5 mM. K+ increases both the level of neuronal 
excitability and the level of Ca+2 influx at the presynaptic terminal. The effect of elevated 
K+ under these conditions was to increase the burst rate consistent with an increase in 
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the extensive pharmacological manipulations, it is significant that the network responded 
to elevated K+ concentrations in a predictable manner (Rhoades and Gross, 1994).  
 
The contribution of metabotropic glutamate receptors (mGluR) to 
neurotransmitter release was examined with the non-selective group I/II antagonist 
MCPG (200 µM).  The compound demonstrated no measurable effect in 5 experiments, 
indicating mGluR activation was not a significant factor in the control of glutamate 
release in our cultures.  This finding is in accord with those of von Gersdorff et al. 
(1997), who showed that mGluR activation apparently contributes to approximately 10% 

































Titrating the extracellular Mg+2 from the normal 0.8 mM to a maximum of 6 mM 
after establishment of NMDAONLY activity resulted in a dose-dependent reduction in the 
burst rate without affecting the burst duration, except at the higher concentrations 
immediately prior to network failure (Fig. 3.8).  Like Ca+2, Mg+2 has multiple sites of 
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Figure 3.8 Effect of increasing Mg+2 concentration on burst rate and burst duration. 
Raising Mg+2 from the basal 0.8mM under NMDAONLY conditions caused a 
progressive decrease in burst rates without affecting burst durations until 4-5mM 
Mg+2. A catastrophic loss of all activity occurred at 6mM Mg+2. Points represent the 
minute means of 14 channels under each pharmacological condition.  
Figure 3.7 Changes in burst duration and burst rate elicited by pharmacological 
manipulation of synaptic driving forces and burst ignition and termination 
mechanisms (minute means from 14 channels, single experiment). The extremely 
low variability of the NMDAONLY activity is indicated by the tight cluster after 
addition of 10µM NBQX (7). Further manipulation by titration of Ca+2 decreases 
both duration and rate, while raising K+ to 8.5mM increases the burst rate.  
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dependent fashion. Increasing the concentration of Mg+2 raises the threshold for relief of 
the voltage dependent blockade. Mg+2 also is implicated in suppression of spontaneous 
activity by charge screening of voltage-sensitive Na+ channels (Guth and Drescher, 
1990). 
 
Compounds affecting receptor desensitization 
 
NMDA receptors undergo different forms of desensitization that potentially could 
contribute to the activity pattern.  Glycine dependent desensitization of NMDA receptor 
mediated currents has been reported in cultured hippocampal neurons (Mayer et al 1989; 
Vyklicky et al., 1990).  Both groups found that 3µM glycine was sufficient to alleviate a 
strong depression of such currents. To test the hypothesis that glycine-dependent NMDA 
receptor desensitization influenced the neuronal network activity under NMDAONLY 
conditions, we added 10 µM glycine to counteract desensitization (n=3).  The glycine 
was without measurable effect, indicating that glycine-dependent desensitization did not 
play a role in generating NMDAONLY oscillations. 
 
.  In addition, the NMDA receptor undergoes a Ca+2 dependent form of 
desensitization that is mediated by the phosphatase calcineurin (Legendre et al., 1993; 
Tong and Jahr, 1994; Tong et al., 1995).  Raman et al. (1996) showed that NE increases 
PKA activity through a β-adrenergic dependent process, which is sufficient to counteract 
the phosphatase actions of calcineurin and to prevent NMDA receptor desensitization.  In 
three experiments, application of 40 µM NE increased burst rates and stabilized IBI at 
NMDAONLY levels.  When NE was applied subsequent to establishment of a stable 
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NMDAONLY pattern, it was without effect. However, NE also inhibits the slow 
afterhyperpolarization (sAHP) that may serve to terminate bursting (Madison and Nicoll, 
1986). Therefore, it is unclear whether the effects produced by NE were a result of 
blocking receptor desensitization or the sAHP.  In either case, the NMDAONLY pattern of 
activity, once established, was not dependent upon a mechanism sensitive to NE. 
 
Compounds affecting afterhyperpolarization 
Action potentials in many excitable cells are followed by a prolonged 
afterhyperpolarization that modulates repetitive firing.  Apamin has been shown to inhibit 
the Ca+2 dependent S(K) current that is responsible for this afterhyperpolarization (Sah 
and McLachlan, 1992).  In our hands, 1 µM apamin (n=4) increased burst rates when it 
was applied prior to blocking AMPA/kainate receptors (Fig. 3.7).  When apamin was 
applied after the NMDAONLY activity was established (n=3), it was without effect.  This 
indicates that the apamin-sensitive AHP does not affect NMDAONLY oscillations. 
 
A transient AHP was identified in hippocampal slices (Alger and Williamson, 
1988) that were sensitive to charybdotoxin (ChTX), indicating its mediation by B(K) K+ 
channels.  We performed experiments with 20 nM ChTX before (n=3) and after (n=3) 
network activity was reduced to NMDAONLY. ChTX increased burst rates when it was 
applied before blockade of AMPA/kainate receptors (Fig. 3.7) but was without effect 
when applied after NBQX.  These results indicate that the Ca+2 activated B(K) channel 
does not dominate NMDAONLY oscillations. 
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Neurotransmitter receptor antagonists 
After the NMDAONLY activity was established, we used atropine (muscarinic 
receptor antagonist, 1-30 µM, n=3), curare (nicotinic receptor antagonist, 10- 20 µM, 
n=3), haloperidol (dopamine receptor antagonist, 2 nM, n=2), methysergide (5-HT1/2 
receptor antagonist, 20 µM,  n=2), Evan's blue (P2X receptor antagonist, 50 µM,  n=2), 
and L-733,060 (tachykinin receptor antagonist, 2 nM, n=2).  None of these compounds 
exhibited measurable effects on previously established NMDAONLY oscillations.  
 
Involvement of electrical synapses and Ih currents 
The functional contribution of gap junctions was investigated with carbenoxolone 
(50-100 µM, n=3). No measurable effect was demonstrated on the NMDAONLY activity, 
indicating that gap junction coupling played no significant role in these oscillations.  
ZD7288 (50 µM, n=3) was used to test for the contribution of the hyperpolarization-
activated cationic conductance (Ih) to NMDAONLY activity.  This agent also was 
ineffective. 
 
Pre- vs post-synaptic control mechanisms 
The addition of 20-50 µM NMDA to the experimental culture medium after the 
NMDAONLY activity was established resulted in increased spike production and a 
disruption of the periodic nature of the activity (Fig. 3.9, n=2).  CVtime for burst rate was 
58% in one network and 71% in the other, indicating that the regular oscillations no 
longer were present.  The disruption of the pattern can be demonstrated in the spike 
frequency domain with Fourier analysis of spike intervals from the same identified units.  
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Figs. 3.9 b and d reveal a drastic alteration in the spike interval structure.  While the 
NMDAONLY activity peaks at 0.34 Hz (b), the addition of NMDA to the medium (d) 
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 C  D 
Figure 3.9 Uncoupling of presynaptic influences by bath application of 50µM 
NMDA destroys the periodic nature of NMDAONLY oscillations. A: 25 s of activity 
of 16 neurons under NMDAONLY conditions. B: The period of the NMDAONLY burst 
oscillation is reflected in the large peak in the power spectra at 0.34Hz (2.94 s 
period) calculated for a sample of 6 of the neurons shown in Panel A. C: The same 
16 neurons 5 min after 50 µM NMDA was added to the experimental bath. The 
periodic and synchronized nature of the NMDAONLY activity is destroyed. D: Power 
spectra calculated for the same neurons as in B after NMDA addition. 
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The NMDA receptor channel possesses a unique voltage dependent Mg+2 block 
that has been shown to induce oscillations in several preparations (Hu and Bourque, 
1999, Rioult-Pedotti, MS, 1997; Wallen and Grillner, 1987). This oscillation is elicited 
by NMDA receptor activation in the presence of physiological levels of Mg+2 and 
apparently is due to the negative slope in the current-voltage relation of the NMDA 
synapse. Wallen and Grillner (1987) showed that NMDA application produced TTX-
resistant oscillations in membrane potential, indicating an intrinsic cellular property.  
Because bath application of NMDA directly activates the receptors independent of 
vesicle release, essentially uncoupling the NMDA synapses from presynaptic influences, 
the loss of regular oscillations strongly suggests that the periodicity under NMDAONLY 















Independent of spontaneous activity or age, 16 spinal cord cultures were entrained 
to a remarkably stable, highly periodic burst pattern of 21.0 ± 2.0 bpm under NMDAONLY 
conditions.  This pattern of activity persisted for up to 12 hours (maximum observation 
time, Fig.3.2d) and more than 98% of all recorded neurons participated (40-85 neurons 
per experiment). NMDA receptor activation was necessary for generation of this unique, 
highly periodic activity pattern, since it was abolished by 40-100 µM APV. However, 
tonic NMDA receptor activation was not sufficient to maintain the periodicity, implying 
that control of the period may originate at the presynaptic level. Additionally, 
disinhibition with BCC and STR and blocking NMDA receptors with APV, leaving only 
the AMPA/kainate synapse as the sole driving force, did not produce the characteristic 
oscillation. 
 
Mechanisms underlying intrinsic burst generation have been explored in several 
different cell types (Azouz et al., 1996; Bracci et al., 1996b; Ballerini et al., 1999; Llinas, 
R.R., 1988; Streit, J., 1993; Traub et al., 1994).  Generally, these investigations have 
analyzed burst phenomena one cell at a time, although population studies using Ca+2 
imaging (Lawrie et al., 1993; Robinson et al., 1993; Wang and Gruenstein, 1997) or 
extracellular field potentials (Staley et al., 1998) have provided insights into network 
bursting. Acutely isolated intact spinal cords, acute spinal cord slices, and organotypic 
slice preparations have been used to study the mechanisms of fictive locomotion and 
putative central pattern generators. For example, elevated extracellular K+ resulted in 
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increased neuronal excitability leading to rhythmic, synchronized oscillations in 
organotypic rat spinal cord slices (Ballerini et al., 1999). These oscillations were network 
dependent as they were blocked by TTX and low Ca+2/high Mg+2 solutions. Comparable 
oscillations also were seen in isolated spinal cord preparations (Bracci et al., 1998). 
 
Interestingly, the burst oscillations reported in these other preparations typically 
show a high degree of variability when compared to our N DAONLY oscillations. For 
example, Ballerini et al. (1999) reported in one experiment a persistent, network-
dependent, rhythmic burst oscillation in ventral horn interneurons with a period of 2.8 ± 
1.5 sec under elevated (6-7 mM) extracellular K+ (a period close to the 2.9 ± 0.3 sec that 
we observed during NMDAONLY activity).  However, in the Ballerini study, the CV of the 
burst period was 20 ± 5% within that one experiment. In contrast, the mean CV for burst 
period in 16 separate experiments we performed was only 3.4% using one-minute bins 
(range 1.4-4.8%). Thus, the NMDAONLY activity was characterized not only by 
remarkable temporal and spatial stability of all burst parameters within individual 
experiments but also by high inter-experiment reproducibility with networks that varied 
widely in age and cell density. This suggests the NMDAONLY network state may be 
unmasking a fundamental cellular mechanism, rather than a circuit-specific network 
property.  
 
CA3 network activity can be dominated by strong synaptic depression, 
presumably induced by depletion of a finite supply of releasable glutamate (Staley et al., 
1998).   They suggested that the period of the population bursts was determined by the 
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rate of refilling of this pool.  Recent investigations have provided insights into the 
dynamics of neurotransmitter vesicle pools (Goda and Stevens, 1998; Ryan et al, 1993; 
Ryan et al., 1996). The RRP in central neurons has been shown to contain from 5-20 
vesicles (Dobrunz and Stevens, 1997; Stevens and Tsujimoto, 1995).  This pool refills 
with a time constant of 5-12 seconds (Rosenmund and Stevens, 1996). High frequency 
stimulation of presynaptic terminals with trains of 100-300 Hz significantly enhances the 
rate of refilling compared to square wave depolarizing input (Wang and Kaczmarek, 
1998). Stevens and Wesseling (1998) reported that the synaptic recovery period was 
reduced from 6 sec to 3 sec when focal hyperosmotic conditions were paired with 
presynaptic 10 Hz stimulation. The recovery time for CA1 synapses depleted by 10 Hz 
stimulation in hippocampal slices was 2.8 ± 2.0 sec (Dobrunz and Stevens, 1997), a time 
remarkably similar to our NMDAONLY period. By comparison, the NMDAONLY bursts in 
our studies produced long plateaus (0.2-0.4 s) at spike frequencies of 200-250 Hz. The 
close agreement between the NMDAONLY oscillation period of 2.9 ± 0.3 sec, and the time 
constants reported for refilling of the RRP during electrical stimulation, in conjunction 
with the results of our pharmacological manipulations implying a presynaptic control of 
the NMDAONLY activity, suggest the vesicle depletion/refilling cycle is a good candidate 
for controlling the period of the unique burst oscillations observed. 
 
Although presynaptic mechanisms may underlie the unique NMDAONLY 
oscillations, it also is necessary to survey postsynaptic responses that can influence spike 
frequencies in bursts as well as burst durations. NMDA receptor activation is associated 
with Ca+2 conductances supporting plateau potentials with effects on burst mechanisms 
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that are not seen with AMPA receptor activation (MacLean et al., 1997).  Calton et al. 
(2000) showed that single stimulation pulses were sufficient to elicit Ca+2 spikes through 
activation of voltage-dependent calcium channels (VDCCs) in pyramidal cells of rat 
amygdala slices.  AMPA receptor-mediated depolarization was unable to elicit these 
spikes, despite providing a greater depolarizing current.  Schiller et al. (1998) showed 
that pairing of glutamate application with postsynaptic action potential firing resulted in a 
threefold increase of Ca+2 entry through the NMDA receptor compared to glutamate 
alone.  In cultured cortical neurons, Robinson et al. (1993) found that Ca+2 oscillations 
concomitant with action potential burst firing were dependent upon NMDA receptor 
activation in low Mg+2 medium. Bacci et al. (1999) established that NMDA receptors, 
along with VDCCs, provide a long-lasting depolarization necessary for support of action 
potential burst firing in cultured hippocampal neurons. These results all highlight the 
unique relationship of the NMDA receptor to intracellular Ca+2 dynamics. Hence, NMDA 
receptor dependent Ca+2 influx is likely to influence the character of the burst generated, 
which, in turn, influences the degree of vesicle depletion at the presynaptic terminal. 
   
In the lamprey, NMDA application induces a robust fictive swimming rhythm that 
is dependent upon NMDA induced Ca+2 currents and Ca+2-dependent K+ currents in 
pacemaker cells (Brodin et al., 1991). Rat spinal neurons exhibit membrane potential 
oscillations in response to NMDA application, which are TTX resistant but are dependent 
upon serotonin (Hochman et al., 1994a; 1994b; MacLean et al., 1998). These membrane 
potential oscillations have been hypothesized to contribute to phasic population activity 
occurring during fictive locomotion, allowing the expression of a precise oscillation 
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period by filtering temporally dispersed synaptic activity (Hochman et al., 1994b). While 
our experiments certainly do not preclude this mechanism from contributing to the 
oscillatory nature of the NMDAONLY activity, the disruption of the periodicity of pre-
existing oscillations by application of NMDA indicate that the receptor alone is not 
sufficient to drive the bursting with great precision.  
 
Staley et al. (1998) speculated that depletion of the excitatory neurotransmitter 
vesicle pool might be necessary for burst termination, with other mechanisms such as 
inhibitory conductances and AHP acting to modulate the postsynaptic effect of glutamate. 
It is of interest that early in postnatal development, GABA application depolarizes 
neurons (Ben-Ari et al., 1997; Menedez de la Prida and Sanchez-Andres, 1999).  During 
this period, bursting patterns of coordinated activity occur (Habets et al., 1987; Jackson et 
al., 1982). This coordinated activity selectively activates subsets of synapses and 
functions as an important mechanism for sculpting circuitry preserved in the adult animal 
(Landmesser and Pilar, 1978; Tosney and Landmesser, 1985). During the period when 
GABA is depolarizing, mechanisms other than fast synaptic inhibition must serve to 
terminate bursting. Strong synaptic depression induced by vesicle depletion would allow 
the coordination of phasic activity between recurrently connected neurons, permitting the 
expression of fundamental motor patterns such as the respiratory rhythm prior to 
establishment of mature synaptic circuitry.  
 
Few neuronal systems can be forced into specific dynamic states with high 
reliability and remain entrained for many hours. The availability of such a stable dynamic 
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system provides a tool for studies of structure/function relationships controlling network 
behavior, excitotoxicity, quantitative assessment of functional synaptic deficits, and 
therapeutic measures designed to restore synaptic efficacy. NMDAONLY activity 
represents a simplification of synaptic driving forces, which will allow the study of 
excitatory-coupled network dynamics and basic burst mechanisms, providing insight into 























Additional Considerations for the use of Cultured Neuronal Networks  
in Basic Neuroscience 
 
 
Many investigators have found that NMDA receptor activation is necessary for 
expression of rhythmic motor drivers in a variety of preparations (Smith and Feldman, 
1987; Daw et al., 1993; Douglas et al., 1993). Application of exogenous NMDA has been 
used to induce rhythmic bursting in intact rat spinal cord (MacLean et al., 1997), in 
medullary slices containing nucleus solitarius neurons (Vincent et al., 1996), in rat spinal 
interneurons (Kiehn et al., 1996), and in cholinergic nucleus basalis neurons (Khateb et 
al., 1995). In the work reported here, the activation of the NMDA receptor by 
endogenous glutamate in the absence of any inhibitory transmission resulted in the 
expression of a remarkably periodic oscillation that was reproduced within networks 
composed of highly variable neuronal numbers with, presumably, equally variable 
neuronal connectivity. The regularity of this NMDA receptor mediated bursting was 
destroyed by bath application of NMDA (Fig. 3.9), in contrast to results of the studies 
cited above. These observations suggest a fundamental mechanism that operates 
predominately on the presynaptic side to produce the observed periodic behavior. 
 
Of course, cultured neuronal networks lack afferent input and make no efferent 
connections. The spontaneous activity that arises within such networks may be 
considered a result of self-excitation within a massively recurrently connected system. 
Under these conditions, isolating presynaptic from postsynaptic contributions to network 
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activity is difficult, as the architecture of the network dictates a continual feedback from 
the postsynaptic to the presynaptic side. We have developed a model to explain the 
unique characteristics of the NMDA receptor mediated activity. This model incorporates 
the special relationship between NMDA receptor activation and Ca+2 entry, which has 
been characterized by a number of investigators (Bacci et al. 1999; MacLean et al., 1997; 
Robinson et al. 1993; Schiller et al., 1998). Even if our model is incorrect in some details, 
it suggests a number of experiments that will help uncover the mechanisms producing the 
highly regular pattern of activity. 
 
Model 
Under conditions of NMDA receptor mediated activity, influx of Ca+2 is 
maximized, through both the NMDA receptor channel and through voltage-dependent 
Ca+2 channels (Calton et al., 2000). The kinetics of NMDA receptor 
activation/deactivation promotes a longer average open time compared to AMPA 
receptor mediated events. The combination of increased Ca+2 conductance and longer 
open time leads to an intracellular Ca+2 concentration that is larger in magnitude and 
more persistent than that seen under other pharmacological conditions. This Ca+2 "plateau 
potential" in turn supports a more depolarized membrane potential than normal. The 
absence of inhibitory conductances prevents repolarization of the neuronal membrane, 
allowing prolonged, high frequency burst firing. It is this relatively long period of intense 
bursting (plateau frequencies of 200-225 Hz for periods of 200-400 ms) that promotes 
complete depletion of the readily-releasable neurotransmitter pool by each burst. The 
high intensity bursting efficiently recruits most of the neurons in the network to 
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participate in each burst episode. With each burst resulting in complete depletion of the 
readily-releasable pool of glutamate, the kinetics of the vesicular recycling mechanism 
become the determining factor in the control of network activity.  Under this scenario, 
initiation of new bursts is dependent upon 1) the recovery of the readily releasable pool to 
a level that supports a reasonable probability of release, and 2) the amount of 
depolarizing input to the network needed to enable the voltage-dependent Mg+2 block of 
the NMDA receptor pore complex to be relieved.  
 
The time constant of recovery for the readily releasable pool has been defined in 
several systems (Dobrunz et al., 1997; Rosemund et al., 1996; Staley et al., 1998; Wang 
and Kacmarek, 1998). If this time is smaller than that required for complete buffering of 
the large intracellular Ca+2 transients elicited by NMDA receptor activation, then average 
membrane potential will be effectively clamped at a sufficiently depolarized level to 
allow initiation of the next population burst as the number of spontaneous EPSPs 
recovers to a threshold level. Experiments to perform Ca+2 imaging in parallel with 
recording of population bursting under several different pharmacological conditions 
could provide an indication of the relative intracellular Ca+2 concentrations reached 
during each condition. Recording of intracellular potentials concomitant with the 
multichannel electrophysiology could provide an indication of the number of EPSPs 
occurring before and after each population burst. Depletion of the readily releasable pool 
is correlated with loss of EPSPs, and recovery of the pool is signaled by an exponential 
increase in the number of EPSPs (Dobrunz et al., 1997; Rosemund et al., 1996). 
Experiments might be performed to manipulate the vesicular recycling process, such as 
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with bafilomycin A, a compound that reversibly inhibits the vesicular ATPase 
responsible for reacidification of the vesicle lumen after endocytosis. This should lead to 
a smaller number of vesicles competent to release neurotransmitter in the readily 
releasable pool. Additional experiments to manipulate the exocytotic machinery with 
Botulinum toxin have been initiated. Such experiments are anticipated to provide 
valuable insights into the mechanisms underlying the highly periodic nature of the 
NMDA receptor dependent activity. 
 
It is hoped that this work provides clear evidence of some of the contributions 
cultured networks can make in areas of basic research. Bursting occurs spontaneously or 
can be elicited in many different preparations by a wide variety of pharmacological and 
electrophysiological stimuli. Cultured networks are ideally suited to study burst 
mechanisms, as they permit long-term simultaneous monitoring of large numbers of 
neurons. Extensive pharmacological manipulations are easily performed, as this work 
clearly demonstrates. Future studies of the contributions individual neurons make to 
population behavior will be greatly facilitated by combining techniques such as laser cell 
surgery with the electrophysiology. Various neurodegenerative and neuropathological 
diseases can be studied in these preparations, which permit simultaneous optical and 
electrophysiological monitoring of cellular and network health and performance. The 






RECOMMENDATIONS FOR FUTURE RESEARCH 
 
Multi-channel recording of electrical activity from cultured neuronal networks 
offers a tool for rapid assessment and detection of a wide variety of chemical and 
biological compounds. This tool, if properly exploited, will benefit applied research in 
areas including drug discovery, toxicological evaluation of environmental contaminants, 
and detection of biological and chemical warfare agents. The examples presented here 
demonstrate the utility of neuronal networks for detecting neurally active compounds and 
for discriminating physiological effects induced by minor molecular differences of 
structurally related compounds. Future work will involve testing and defining a large 
number of substances based on the effects they produce on neuronal network activity, and 
the creation of a library of substance "fingerprints". When fully implemented, this will 
allow identification of an unknown compound by comparison of the effects it induces to 
the library of previously tested substances. This study will help define the parameters of 
that library. 
 
The effect induced by bath application of a substance on the electrical activity of a 
particular cell embedded in a neuronal network, is an integration of the effects mediated 
by the receptor population that cell expresses, together with the effects produced via 
chemical and electrical synaptic inputs from all other cells that make contact with the 
neuron in question. This integration complicates analysis of mechanisms of action of a 
particular substance, but allows prediction of the functional consequences of a specific 
 110 
compound on a behaving animal. Analyzing responses to neuroactive agents may be done 
on the single cell or the network level. Such analyses may report changes in excitability 
with rate histograms, changes in patterns of action potentials with inter-spike intervals, or 
changes in network coordination with cross-correlograms. The level of analysis (single 
cell or network) and the set of parameters used for analysis are substance and experiment 
specific. Simply reporting that a compound has caused a cessation of all activity at a 
particular reproducible concentration is valuable information in the screening for neurally 
active drugs. Examination of the single cell dynamics of that global inhibition may be 
necessary for understanding the mechanism of the effect.   
  
Healthy neuronal networks express a population of receptors that can be 
addressed by a wide variety of pharmacological agents. When a specific receptor type 
binds an appropriate ligand, the effects that receptor mediates on neuronal excitability 
may be observed. Reliable dose-response curves may be produced for a wide variety of 
compounds, so long as data from the test period are normalized relative to an 
experimentally determined reference period of activity. The concentration required to 
elicit a particular effect in the neuronal networks may be different from that observed in 
other preparations but in many cases the direction of that effect in the other preparations 
may be accurately predicted from the neuronal network data. For example, a compound 
that causes synchronized, high frequency oscillations in a neuronal network almost 
certainly will be epileptogenic in an i vivo preparation, or a compound that totally 
inhibits network activity without causing cytotoxicity can be predicted to produce 
catatonia in vivo. Of course, if this inhibition occurs in the medulla to the extent that it 
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adversely impacts respiration, death may also result. In either case, the network responses 
can be qualitatively related to the in vivo effects.  
 
Analysis and interpretation of data obtained from multiple, simultaneous spike 
trains is an emerging area of science. The work in this lab in the past has focused on the 
analysis of integrated data, which minimizes the contributions of single action potentials, 
but does allow the quantification of multiple burst parameters from the simplified dataset. 
Current technology has evolved to the point that acquisition and analysis of high rate, 
large data files is routine. This makes the analysis of single spike data feasible. However, 
the problem becomes one of selecting the parameters necessary to capture the essence of 
the neuronal network activity changes while providing an easily interpretable analysis of 
effects induced by experimental manipulation.  
 
It is likely that future data analysis techniques will incorporate a multivariate 
approach, with different activity parameters plotted orthogonally to yield cluster plots of 
network activity states under various condition (see for example Fig. 3.8). Dynamics of 
the clusters as network activity evolves in response to an experimental manipulation will 
provide a Gestalt of network behavior. This approach should allow neuronal network 
analysis capabilities to include actual identification of unknown substances. The relative 
changes of the different activity variables elicited by a particular compound will provide 
insights into the mechanisms being affected.  
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Initial attempts at performing such a multivariate analysis have proved fruitful. In 
collaboration with Alexandra Gramowski, a series of experiments were performed to 
characterize the effects of 40 µM bicuculline applied both singly (n=23) and in 
combination with 1 µM strychnine (n=27) on spinal cord networks. Two subsequent 
experiments were performed in which bicuculline and the bicuculline/strychnine 
combination were applied in a blind test. An analysis of 13 different measures of network 
activity, which then were compared to the response database, allowed the correct 
identification of the test substances. All analyses were performed off-line in a labor-
intensive manner. These analytic approaches, and more sophisticated ones such as the 
cluster plots discussed above, should be implemented in real time, allowing the 
experimenter to adjust conditions to maximize information obtained from a particular 
experiment. 
 
Several future uses for neuronal networks will rely on the ability to 
simultaneously process a large number of different samples.  For example, cell-based 
drug screening of thousands of compounds requires separate cell cultures, usually 
contained in 96- or 384-well plastic containers conducive to assay using optical 
approaches. Clearly, the number of assays that can be performed with a singleculture of 
cells on microelectrode array will be relatively low.  The viability of many cell types, 
especially neurons, depends on the continuous availability of soluble factors, which 
would be depleted as the cells are exposed to samples instead of culture media.  Even if 
complex engineering methods were to be employed to mitigate the dilution of culture 
media, continuous exposure of a single cell population to a series of environmental 
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samples would still be necessary.  This would seriously complicate the interpretation of 
any single assay.   
  
One approach to this problem would be construction of a massively parallel 
version of the microelectrode arrays across a set of separate, miniature culture wells.  
This would allow each culture to be used for a single assay, obviating problems 
associated with the loss of soluble factors and the interpretation of results.  Thus, the 
throughput of the system could be increased in proportion to the number of miniaturized 
culture wells that contain microelectrodes.  
 
 Multi-network arrays will find application in the biosensor arena, as well. The 
anticipated design would allow administration of environmental samples (after necessary 
concentration and pre-treatment) to a test network, while one network remains isolated 
from outside influences. Thus, should the activity of the test network be altered markedly 
by the environmental sample and the control network activity remain stable, the cause of 
the change in test network activity can be ascribed with a high level of confidence to the 
presence of a neurally active compound in the environment. Alternatively, should both of 
the networks exhibit parallel changes in activity, problems with environmental control 
systems must be suspected. Incorporating more than two networks in the biosensor would 
permit redundancy in the detection process. Of course, each increase in the number of 
networks will require a corresponding increase in the complexity of the programming 
necessary to permit the biosensor to operate autonomously.    
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Currently, neuronal networks are not yet ready for field deployment.  However, 
meaningful physiological information now can be obtained from neuronal networks. The 
most significant hurdle that remains is that the cells themselves are not comparably 
“stable,” compared to other sensing elements such as antibodies or nucleic acid probes, 
meaning that a continual supply of replacement cultures must be available. Under 
laboratory standard cell culture conditions, the lifetime of neuronal networks can exceed 
300 days (Gross 1994).  Presently, cryopreservation of intact neural networks for long-
term storage has not been demonstrated, although spontaneously active networks have 
been grown from cells cryopreserved for periods of up to six months at –80o C. These 
cells formed networks of neurons and glia that were morphologically indistinguishable 
from those formed from unfrozen cells. Pharmacological tests revealed normal responses 
to most common neurotransmitters, such as GABA, glycine, glutamate, and ACh. 
However, there seemed to be deficiency in the expression of the NMDA receptor 
(unpublished observations). These results are promising enough to encourage further 
experimentation. An approach that encourages stabilization of the cellular cytoskeleton 
with compounds such as taxol, in combination with improvements in the cryopreservative 










During the past three-and-one-half years, I have performed approximately 300 
experiments with cultured neuronal networks. This experience has provided some 
insights into the limitations of this preparation in its present form. A list of the problems 
include but certainly are not limited to: a) variability in activity between cultures, b) 
tissue-specificity of receptor expression, c) systematic experimenter errors in areas such 
as drug concentrations and application trauma, and d) difficulty of testing non-water 
soluble compounds. Each of these factors can produce highly variable results from 
culture to culture and between different experimenters. However, understanding the 
sources of this variability often can allow appropriate compensations to be made and 
enable valuable data to be salvaged. 
 
Activity Variability 
Experience has shown that the dynamic range of spontaneous activity within 
separate cultures can be from zero to over 60 bursts/min, and mean spike frequency 
variability is even greater. This disparity in the spontaneous activity virtually requires 
that comparisons of responses elicited by a particular compound be performed using 
normalized values. In this way, data generated by different networks can be pooled, and 
mean and standard deviations of the response can be calculated. Of course, for testing an 
unknown compound, it would seem that a culture with spontaneous rates somewhere in 
the middle of the dynamic range would be the most reliable detector. Thus, if a substance 
is inhibitory, the activity can be suppressed. If excitatory, the activity can increase 
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without exceeding the physiological limits of the neurons. Often, if the spontaneous 
network activity is low, application of a disinhibitory compound such as bicuculline, or 
an excitatory compound, such as glutamate, can elicit increased spiking and bursting. If it 
is undesirable to interfere with a neurotransmitter system, elevations in the external K+ 
concentration can produce a generalized excitation. At the other extreme, cultures that are 
overly active may be slowed by increasing external Mg+2, which both decreases 
neurotransmitter release probability and increases the threshold for NMDA receptor 




Cultured neurons retain the pharmacological responsiveness of the tissue from 
which they were obtained. Thus, a culture grown from tissue harvested from the spinal 
cord responds to application of glycine or to the glycinergic antagonist strychnine. 
Frontal cortex cultures on the other hand, show much weaker responses to glycine or 
strychnine. An application of 10 µM ACh to frontal cortex will produce robust increases 
in both bursting and spiking, whereas the spinal cord does not respond to ACh until the 
concentration is raised to 100-150 µM. Medulla cultures reliably increase spiking activity 
in the presence of as little as 1 µM ACh. However, of the three tissues, only the frontal 
cortex cultures seem to possess functional cholinergic synapses, since AChE inhibitors, 
such as eserine, cause changes in spontaneous activity that parallel those caused by 
application of exogenous ACh. Results such as these demonstrate the preservation of 
tissue-specific receptor and neurotransmitter expression in cell culture. This specificity 
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can cause confounding results. Depending upon the mechanisms a specific test compound 
affects, it may be essentially invisible to one tissue, yet produce robust responses in 
another tissue type. 
 
Experimenter Errors 
Working with neuronal networks requires a facility with certain laboratory 
practices. For example, a common experimental paradigm when testing pharmacological 
compounds requires the culture to be “washed,” meaning that the medium containing the 
test substance is exchanged with fresh medium. The number of washes required to 
reverse the effects elicited by the test compounds is a function of several variables, 
including concentration applied, solubility, and the intrinsic reversibility of the 
compound. In the open chamber configuration used in all the experiments described in 
this work, the experimenter must manually remove the medium with a pipette or syringe, 
and immediately replace it. The sudden change in medium can have several detrimental 
effects on neuronal networks. The open chamber allows constant evaporation from the 
experimental bath, which permits the osmolarity of the medium to gradually increase 
with time. If the experimenter neglects to maintain the osmolarity with periodic additions 
of distilled water, a medium change can result in a sudden osmotic shock that will disrupt 
the network activity. If the osmotic change is too great, neuronal swelling and synaptic 
disruption may occur. The changes in cellular morphology may be observed through the 
microscope. Network activity may also be disrupted by the physical shock of a medium 
change if the experimenter carelessly applies the fresh medium at too fast a rate or 
directly to the neuronal culture. The network may be killed if the experimenter is too 
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slow to replace the medium and the network dries out. Network activity also will be  
disrupted if the pH of the fresh medium is not adjusted to a physiological range of 7.3-
7.4. Other experimenter errors may occur in the application of test substances. Stock 
solutions should be of a sufficient concentration to minimize the volume added to the 
experimental bath. Sudden additions of large drug volumes may be as osmotically 
disruptive as those caused by sudden medium changes.  
 
The experimenter must be careful to ensure that the concentration of the drugs 
added is calculated correctly. The stability of the compound must also be considered. The 
sensitivity of the neuronal networks means they can easily detect degradation of test 
substances with time. If an experimental response to a calculated drug concentration is 
depressed as compared to the response seen in previous experiments, a fresh stock 
solution should be tested. This often will restore the network responsiveness.  
 
Solubility 
Neuronal networks are bathed in an aqueous medium, a factor that complicates 
analysis of some test substances. Many of the cannabimimetic agents for example, are 
only moderately to relatively insoluble in water. The degree of solubility varies with the 
size of the molecule in question and the number of double bonds it contains. Compounds 
such as the military grade jet fuels JP-4, JP-5, and JP-8 have been tested with the 
networks. These hydrocarbon compounds are virtually insoluble in water. Various 
strategies have been employed to compensate for some of these properties. In the case of 
the cannabimimetics, addition of a carrier molecule such as bovine serum albumin (BSA) 
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is sometimes useful. Sonication for extended periods often can yield a relatively clear test 
solution. The aircraft fuels were tested by creating micelles, produced by sonicating a 
mixture of BSA, water, and fuel. This allowed the test substance to be introduced into the 
experimental bath, but the concentration that actually dissolved into the bath remained 
unknown. In the case of the cannabimimetics anandamide, methanandamide, and a 
related molecule palmitoyl ethanolamide, post-experimentation comparison of calculated 
concentrations with actual concentrations using gas chromatography/mass spectrometry 
revealed that the calculated concentrations were as much as 70 times higher than the 
concentration delivered to the neuronal network (Morefield et al., 2000). Obviously, 
errors of this magnitude must be resolved before responses observed in the network can 
be compared to those generated with other preparations.  
 
Some compounds are soluble only in liquids such as ethanol or DMSO. For 
substances that must be administered in these carriers, care must be taken to minimize the 
amount of solvent to which the network is exposed. This means that stock solutions must 
be made at the highest concentration possible. Control studies must be performed to 
determine the response of the networks to equi-volume amounts of solvent without the 
test compound. Experience has shown that additions of less than 0.5% v/v DMSO or 
0.3% v/v ethanol produces very little effect on network activity. For lipophilic 
compounds such as the cannabimimetics, reversibility of the effects may be problematic, 
as the compound can incorporate directly into the neuronal membrane, effectively 
stabilizing the concentration at an undetermined level. For experiments in which exact 
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quantitative data are required, as the construction of dose-response curves, this 
characteristic can limit the number of drug applications possible with a single network.  
 
Additional Considerations 
This work has demonstrated applications of neuronal networks in three different 
areas of neuroscience. As the technology for acquiring and analyzing the large data sets 
generated by multichannel recording matures and decreases in cost, neuronal network 
uses will inevitably spread beyond this laboratory. As the sophistication of life support 
systems and drug administration increase, the reliability of data generated by neuronal 
network research will also increase. The availability of a library of compound responses 
will allow rapid determination of novel drug mechanisms by comparing response profiles 
and facilitate the deployment of neuronal networks as autonomous biosensors for military 
and strategic protection uses. Recent work reporting the synergistic effects of the 
common agricultural chemicals maneb and paraquat in producing Parkinson-like 
symptoms in mice (Thiruchelvam et al., 2000) signals a burgeoning area of toxin 
evaluation that will require new, rapid approaches such as those possible with neuronal 
networks. The list of potential toxins is long and diverse, including the obvious, such as 
organophosphate pesticides, and the more elusive, such as microbial defense toxins. The 
potential for neuronal network applications is only beginning to be appreciated. Works 
such as this will help define the problems for which neuronal networks are best suited, 
and will highlight the limitations that current technology and experimental practices place 
on their immediate use outside of a laboratory setting. The most powerful demonstration 
of neuronal network capabilities will arise from supplementing the multichannel 
 121 
electrophysiology with other techniques, including intracellular recording, Ca+2 im ging, 
and analysis of changes in expression levels induced by experimental manipulations. 
With adjunct methods such as these providing converging lines of evidence, neuronal 
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